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A B S T R A C T
Background
Experiencing anxiety and depression is very common in people with dementia and mild cognitive impairment (MCI). Psychological
interventions have been suggested as a potential treatment for these populations. Current research suggests that people with dementia
and MCI have limited opportunities for psychological treatments aimed at improving their well-being. A systematic review of the
evidence on their effectiveness is likely to be useful in terms of improving outcomes for patients and for future recommendations for
practice.
Objectives
The main objective of this review was to assess the effectiveness of psychological interventions in reducing anxiety and depression in
people with dementia or mild cognitive impairment (MCI).
Search methods
We searched theCochrane Dementia and Cognitive ImprovementGroup Specialized Register and additional sources for both published
and unpublished data.
Selection criteria
We included randomised controlled trials (RCTs) comparing a psychological intervention with usual care or a placebo intervention
(social contact control) in people with dementia or MCI.
Data collection and analysis
Two review authors worked independently to select trials, extract data and assess studies for risk of bias, using a data extraction form.
We contacted authors when further information was not available from the published articles.
Main results
Six RCTs involving 439 participants with dementia were included in the review, but no studies of participants with MCI were
identified. The studies included people with dementia living in the community or in nursing home care and were carried out in several
countries. Only one of the studies was classified as low risk of bias. Five studies were at unclear or high risk of bias due to uncertainties
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around randomisation, blinding and selective reporting of results. The studies used the different psychological approaches of cognitive
behavioural therapy (CBT), interpersonal therapy and counselling. Two studies were of multimodal interventions including a specific
psychological therapy. The comparison groups received either usual care, attention-control educational programs, diagnostic feedback
or services slightly above usual care.
Meta-analysis showed a positive effect of psychological treatments on depression (6 trials, 439 participants, standardised mean difference
(SMD) -0.22; 95% confidence interval (CI) -0.41 to -0.03, moderate quality evidence) and on clinician-rated anxiety (2 trials, 65
participants, mean difference (MD) -4.57; 95% CI -7.81 to -1.32, low quality evidence), but not on self-rated anxiety (2 trials, SMD
0.05; 95% CI -0.44 to 0.54) or carer-rated anxiety (1 trial, MD -2.40; 95% CI -4.96 to 0.16). Results were compatible with both
benefit and harm on the secondary outcomes of patient quality of life, activities of daily living (ADLs), neuropsychiatric symptoms
and cognition, or on carers’ self-rated depressive symptoms, but most of the studies did not measure these outcomes. There were no
reports of adverse events.
Authors’ conclusions
We found evidence that psychological interventions added to usual care can reduce symptoms of depression and clinician-rated anxiety
for people with dementia. We conclude that psychological interventions have the potential to improve patient well-being. Further high
quality studies are needed to investigate which treatments are most effective and to evaluate the effect of psychological interventions in
people with MCI.
P L A I N L A N G U A G E S U M M A R Y
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Symptoms of depression and anxiety are common in people with dementia and mild cognitive impairment (MCI). Although treatment
of these symptoms is widely recommended in guidelines, the best way to do this is not clear. Drugs are thought to have limited
effectiveness in this context and carry the risk of significant side effects. Psychological treatments can be adapted for use with people
with cognitive impairment and may offer an alternative treatment.
This review identified six randomised controlled trials, including 439 participants, in which a psychological treatment for people with
dementia was compared to usual care. Most participants had mild dementia, but one trial was conducted with nursing home residents
who had more severe dementia. We found no trials of participants with MCI. The psychological interventions used were based on
established psychological models such as cognitive behavioural therapy (CBT), counselling, and interpersonal psychodynamic therapy.
In two trials, the psychological treatment was combined with other interventions. We found evidence that psychological treatments can
reduce depressive symptoms in people with dementia. There was also some evidence from two trials that CBT may reduce clinician-
rated anxiety symptoms in people with mild dementia. Due to the imprecision of our results, we could not tell whether psychological
treatments had an effect on patients’ quality of life, ability to perform daily activities, overall psychiatric symptoms, or cognition, or on
carers’ self-rated depressive symptoms, but most studies did not measure these outcomes.
Although these results are promising, the small number of studies and the variation between them in the type and duration of treatment
make it difficult to draw conclusions about the best way to provide psychological treatment for people with dementia who have
symptoms of depression or anxiety. More high quality trials in this area would be beneficial, including trials involving participants with
MCI.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Psychological treatment compared to treatment as usual for depression and anxiety in dementia and mild cognitive impairment
Patient or population: Patients with depression and anxiety in dementia and mild cognit ive impairment
Settings: Community, resident ial care
Intervention: Psychological treatment
Comparison: Treatment as usual
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Treatment as usual Psychological treat-
ment
Depression
Geriatric Depression
Scale (range of scores
0-15, 0-30), Cornell
Scale for Depression
in Dementia (range of
scores 0-38), Mont-
gomery-Asberg Depres-
sion Rating Scale
(range of scores 0-50)
Follow-up: 6 - 48 weeks
The mean depression in
the intervent ion groups
was
0.22 standard devia-
tions lower
(0.41 to 0.03 lower)
439
(6 studies)
⊕⊕⊕©
moderate1
SMD -0.22 (-0.41 to -0.
03)
Anxiety RAID
Rating Anxiety in De-
mentia. Scale f rom: 0 to
54.
Follow-up: 15 - 48
weeks
The mean anxiety RAID
ranged across control
groups f rom
17.89 to 17.2 points2
The mean anxiety RAID
in the intervent ion
groups was
4.57 lower
(7.81 to 1.32 lower)
65
(2 studies)
⊕⊕©©
low3,4
Higher scores indicate
higher levels of anxiety
symptoms
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Anxiety Self ratings
Hospital
Anxiety and Depression
Scale (range of scores
0 - 21), Geriatric Anxi-
ety Inventory (range of
scores 0-20)
Follow-up: 15 - 48
weeks
The mean anxiety self
rat ings in the interven-
t ion groups was
0.05 standard devia-
tions higher
(0.44 lower to 0.54
higher)
65
(2 studies)
⊕⊕©©
low5,6
SMD 0.05 (-0.44 to 0.
54)
Anxiety NPI-A
Follow-up: 6 months
The mean anxiety NPI-
A in the intervent ion
groups was
2.4 lower
(4.96 lower to 0.16
higher)
26
(1 study)
See comment Higher scores indicate
higher levels of anxiety
symptoms
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 In two of the studies blinding of outcome assessment is not suf f icient ly reported. There is evidence of select ive report ing
at least in 1 study. Only 1 study describes blinding of personnel.
2 These values are based on scores in the control group across studies in the systematic review
3 Potent ial select ion bias in one of the studies included (allocat ion concealment was not specif ied).
4 Small number of studies
5 Potent ial select ion bias in one of the studies included (allocat ion concealment was not specif ied).
6 Small number of studies
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B A C K G R O U N D
Description of the condition
There are particular difficulties defining and diagnosing depres-
sion in the context of dementia. It is only relatively recently that at-
tempts have beenmade to produce inclusion and exclusion criteria
for the diagnosis of depression specifically in Alzheimer’s disease
(AD), based on affective and behavioural features (Olin 2002).
Prevalence rates of depressive symptoms in people with dementia
range from 10% to 62% (Enache 2011), with lower rates (0.9%
to 4.8%) reported when employing strict criteria for major de-
pression (Weiner 2002). A recent review shows that approximately
20% to 30% of patients with AD have depression, with higher
rates in vascular dementia (VaD) and dementia with Lewy bodies
(DLB) (Enache 2011). Being of younger age, experiencing sig-
nificant medical conditions or having a family history of depres-
sion increases the risk of experiencing depressive symptoms (Gellis
2009). InMCI, rates of depressive symptoms are reported as mod-
erate to high, ranging from 36% (Palmer 2007) to 63% (Solfrizzi
2007).
Although anxiety symptoms are common both in dementia and
MCI (Absher 1994; Hwang 2004), there is a lack of consensus
about how to define and conceptualise anxiety in dementia. Stud-
ies have employed diagnostic criteria (for example the Diagnos-
tic and Statistical Manual of Mental Disorders-IV (DSM-IV)) or
measures of anxiety symptomatology (Ferreti 2001). There are
contrasting views in the literature as to whether anxiety and agi-
tation are the same or different constructs (Ballard 1996; Hersen
1992). Recently Starkstein 2007 proposed a revision of diagnos-
tic criteria for generalized anxiety disorder (GAD) in individuals
with dementia consisting of excessive anxiety and worry (criteria
A and B of the DSM-IV) and any three of the symptoms of rest-
lessness, irritability, muscle tension, fears and respiratory symp-
toms. Prevalence estimates in dementia range from 8% to 71%
for symptoms of anxiety (Ballard 2000) and 5% to 21% for anx-
iety disorders (Ferreti 2001). In people with MCI, anxiety symp-
toms range from 10% to 74% (Monastero 2009). Relatively less
is known about the prevalence of anxiety disorders in MCI, with
rates up to 49% (Lopez 2005) when using the Consortium to Es-
tablish a Registry for Alzheimer’s Disease Behavioral Rating Scale
for Dementia (CERAD-BRSD) criteria. It is notable that anxiety
and depression can coexist in individuals with dementia and MCI
with common symptoms across both affective states, which can
add to the difficulties of definition (Seignourel 2008).
Previous studies indicate that the frequency of depressive and anx-
iety symptoms varies as a function of the severity of dementia.
For example, experiencing depression is more common in patients
withmild tomoderate dementia, whereas elevated levels of anxiety
may be more frequent in later stages of the disease (Lopez 2003).
Different types of dementia (for example vascular versus AD) have
also been associated with different prevalence rates of depression
and anxiety (Groves 2000; Sultzer 1993).
Regarding the impact of the conditions, consistent evidence sug-
gests that the severity of depression increases the severity of neu-
rological impairments, institutionalisation (Lyketsos 1997; Stern
1997), and levels of caregiver burden (Gonzalez-Salvador 1999)
in people with dementia. Anxiety is associated with decreased in-
dependence (Schultz 2004), increased risk of nursing home place-
ment (Gibbons 2002), and can lead to an overestimation of de-
mentia severity (Yesavage 1984). Early symptoms of depression in
MCI can be persistent and refractory to antidepressant medication
(Devanand 2003), and increase the risk of developing dementia at
follow-up (Li 2001). In fact both depressive (Gabryelewicz 2004)
and anxiety symptoms (Palmer 2007) in people with MCI predict
higher rates of progression to AD (Lu 2009) and are often impli-
cated in greater impairments in activities of daily living (Rozzini
2009).
Description of the intervention
The main psychotherapeutic approaches in treating depression
and anxiety in adults, according to the World Health Organiza-
tion (WHO), are cognitive behavioural therapy (CBT), psychody-
namic therapy, interpersonal therapy (IPT), and supportive coun-
selling (Rogerian person-centred therapy) (WHO 2007). Previ-
ous work has concluded that offering psychotherapy to older peo-
ple is worthwhile as it promotes improvements in depression and
increases general psychological well-being as well as reducing de-
pression in seniors with mental disorders (Pinquart 2001). How-
ever, several systematic reviews of psychological treatments in older
adults experiencing depression (Gould 2012; Wilson 2008) find
that there is currently no strong support for psychotherapeutic
treatments in themanagement of depression in older adults due to
the paucity of high quality research (Gould 2012; Wilson 2008).
Recent studies indicate that specific biological and psychological
aspects of aging such as executive dysfunction may impact on the
effectiveness of treatments for late life depression and anxiety dis-
orders (Areán 2010; Mohlman 2005). Several studies have inves-
tigated the benefits of adapting psychological therapies in order to
accommodate age-related clinical diversity (Yost 1986). Amongst
the adaptations are the emphasis on behavioural techniques, use
of different sensory modalities and repeating information in or-
der to compensate for age-related losses in attention and declining
sensory function (Grant 1995).
A wide variety of psychological interventions have been stud-
ied within the context of improving affective function for pa-
tients with cognitive impairment. Behavioural management ther-
apy techniques include specific caregiver training to reduce the oc-
currence of behavioural symptoms and modify precipitants of pa-
tient distress that impair daily functioning Teri 2003. Relaxation
therapy or traininghas oftenbeenused as an attentionplacebo con-
trol comparison in psychological therapy trials, but recent reviews
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(Borkovec 2001; Gould 1997) have considered this approach as an
active behavioural therapeutic intervention. Other psychothera-
pies (that is psychodynamic, interpersonal therapy, supportive psy-
chotherapy), where the primary focus is to increase patient well-
being and psychological function (Rosenthal 1999), have been less
frequently evaluated in people with dementia. It should be noted
that there are several areas of overlap between these therapies and
current research suggests that the various approaches are not used
in isolation (Ballard 2001).
Although there are a number of other types of interventions which
incorporate some psychological elements and which are used to
target anxiety and depression in dementia, for example reminis-
cence (Woods 2012) and interventions focusing on environmental
changes (Gitlin 2003) or exercise (Rolland 2007), the present re
view focuses on psychological interventions, that is interventions
primarily based on psychological models as defined by WHO
2007. Interventions that involve reminiscence therapy are the sub-
ject of another Cochrane review (Woods 2012).
How the intervention might work
Most psychotherapies emphasize dysfunctional beliefs as well as
incorporating components of behavioural therapy aiming to chal-
lenge negative cognitions that maintain depressive symptomatol-
ogy and anxiety symptoms (WHO 2007). An important com-
ponent of CBT is monitoring and identifying thoughts and be-
haviours that contribute to depression or anxiety, or both (Beck
1979). Treatment components of CBT for anxiety in older adults
often include additional techniques such as teaching older adults
relaxation skills (Stanley 2004). Modifications of CBT target cog-
nitive strategies in early-stage dementia and behavioural strategies
in later stages, by aiming to reduce the cognitive load on the per-
son by increasing repetition of information and utilizing concrete
examples (Gellis 2009). Amongst the modifications to the thera-
peutic process for people with dementia are slowing the pace of
therapy and simplifying patient-therapist communications (Robie
1999). Implementing CBT in people with cognitive impairment
requires providing the therapy in a highly structured format as
well as monitoring that participants understand the therapeutic
material presented (Gellis 2009).
Behavioural therapies for people with dementia involve both pa-
tients and caregivers in the therapeutic approach Teri 2003. In
these training programs caregivers are encouraged to identify
pleasant activities for patients, which encourage positive interac-
tions and increase the involvement of physical and social activ-
ity Teri 2003. Other psychological therapies (that is supportive
psychotherapy) encourage focusing on past successes and limiting
social contacts to those that are reinforcing and emotionally re-
warding (Novalis 1993).
Why it is important to do this review
Recent recommendations stress that the treatment of anxiety and
depressive symptoms should be an essential part of the treatment
of AD and other dementias (Alexopoulos 2005; Azermai 2012).
Currently, pharmacological approaches are commonly used for
anxiety and depression in dementia, despite recent research sug-
gesting poor efficacy and side effects of antidepressants (Banerjee
2011). Symptoms of anxiety and depression may contribute to the
overuse of antipsychotics, which are associated with substantial
adverse effects such as an increased risk of sedation, falls and death
(van der Hooft 2008). Evidence that more than 40% of people
with dementia are being prescribed antipsychotic drugs indicates
inappropriate and unnecessary prescribing (Margallo-Lana 2001).
Althoughmost current clinical practice guidelines (Salzman 2008)
recommend the use of non-pharmacological interventions as the
first line of approach in treating both anxiety and depression in
dementia (Hogan 2008), empirical evidence supporting the effi-
cacy of psychological interventions is rather sparse (Doody 2001).
Previous reviews have concluded that there is a lack of evidence
that psychological treatments improve patients’ affective function
(Douglas 2004; Lyketsos 2002a), however these reviews often in-
clude a broad family of interventions that are termed ’psycholog-
ical’. The evidence base, therefore, for psychological treatment in
dementia is based on reviews of studies that include a variety of
behavioural and cognitive treatments that are not based on well-
defined theory-driven psychological interventions or are not pri-
marily aimed at people with dementia.
The results of the present review will be useful for establishing
guidelines and recommendations for reducing depression and anx-
iety in older adults with cognitive impairment, given that current
evidence is inconclusive.
O B J E C T I V E S
Primary objective
To assess the effectiveness of (1) psychological interventions in
reducing anxiety and depression in people with dementia or mild
cognitive impairment (MCI).
Secondary objectives
To determine whether (2) psychological interventions improve pa-
tient quality of life, cognition, activities of daily living, and reduce
behavioural and psychological symptoms of dementia other than
anxiety and depression compared to usual care, and (3) whether
psychological treatments improve caregiver quality of life or re-
duce carer burden.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
We included studies in this review if they fulfilled the following
criteria:
• they were randomised controlled trials (RCTs), including
cluster randomised trials;
• included a control group (usual care) or a comparison
group receiving no specific psychological intervention;
• provided adequate information about study design and
results (including means, standard deviations (SDs), and
numbers of participants (n));
• provided separate data on participants with dementia and
MCI if the study was of a mixed population (e.g. also including
older adults with normal cognition).
Ongoing studieswere identified butwere not included in themeta-
analysis.
Types of participants
The inclusion criteria for participants were:
• older adults diagnosed with dementia, Alzheimer’s disease,
organic brain syndrome, etc. according to the DSM-IV,
International Classification of Diseases-10 (ICD-10), or
comparable, and participants with a diagnosis of mild cognitive
impairment (MCI). Any definition of MCI was acceptable as
long as the criteria used were published and included evidence of
objective cognitive impairment but no dementia (e.g. Petersen
1999; Petersen 2003; Visser 2005);
• any setting (e.g. home, community, institution).
Types of interventions
For the purposes of this review, we defined a psychological inter-
vention as an intervention that: (a) was designed to reduce anxiety
and depression or improve adaptive functioning, or both, b) was
based on a psychological theory (for example learning theory), and
c) involved a structured interaction between a facilitator and a par-
ticipant which incorporated psychological methods (for example
behavioural, cognitive behavioural, family systems), in line with
previous meta-analytic studies (Pai 2006). We included interven-
tions facilitated by psychologists, therapists in training, and other
trained professionals. We grouped eligible interventions, where
possible, into the following.
1. Cognitive behavioural therapies (which include cognitive
behavioural therapy (CBT), cognitive analytic therapy (CAT),
behavioural therapy, behaviour management therapy, brief
rational insight and problem-solving therapy).
2. Relaxation training therapies (i.e. progressive muscle
relaxation).
3. Psychodynamic therapies (including brief psychotherapy
and insight orientated psychotherapy).
4. Interpersonal therapies (ITP).
5. Supportive or counselling therapies.
We excluded treatments identified as medication, exercise, remi-
niscence therapy, music therapy, art and drama therapy, befriend-
ing or bibliotherapy. If an intervention could not be grouped into
any of the preceding categories, we classified it as psychological and
included it in the review if there was some attempt to teach par-
ticipants skills to reduce psychological distress such as depression
and anxiety. We included both individual and group psychother-
apies. The psychotherapy could be of any intensity, duration or
frequency. Control conditions included no treatment (usual care)
or a comparison group engaging in non-specific psychosocial ac-
tivity (for example attention-control, by controlling for effects of
staff attention or social contact). We did not consider compar-
isons with other therapeutic interventions in this review. We in-
cluded studies that used combinations of different psychological
treatments, or combinations of pharmacological and psychologi-
cal interventions. In the case of combinations of pharmacological
and psychological treatments, a comparison group of the pharma-
cological intervention alone or with the above control treatments
was required.
Types of outcome measures
We included studies if they reported an outcome measure of de-
pression or anxiety, measured by a standardised test.
Primary outcomes
• Measures of depression (e.g. Cornell Scale for Depression in
Dementia, Hamilton Depression Scale, Beck Depression
Inventory, Geriatric Depression Scale) and anxiety (e.g. The
Worry Scale, Rating of Anxiety in Dementia Scale). We included
clinician, carer and patient ratings.
Secondary outcomes
• Measures of patient quality of life, cognition, daily activity
level (e.g. ADLs), and frequency of neuropsychiatric symptoms
(e.g. Neuropsychiatric Inventory (NPI))
• Caregivers’ quality of life, and experience of caregiver
burden
Search methods for identification of studies
Electronic searches
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We searched ALOIS (www.medicine.ox.ac.uk/alois) - the
Cochrane Dementia and Cognitive Improvement Group (CD-
CIG) Specialized Register. We searched all “Treatment MCI” and
“Treatment Dementia” studies in combination with the following
terms or phrases: Depression or Dysthymi* or “Adjustment Disor-
der/s” or “MoodDisorder/s” or “AffectiveDisorder/s” or “Affective
Symptoms”, Anxiety or Anxious or phobia/s or “Panic Disorder”,
psychotherapy, “cognitive therapy”, “behaviour therapy”, “cogni-
tive behaviour therapy”. ALOIS is maintained by the Trials Search
Co-ordinator for CDCIG and contains dementia and cognitive
impairment studies identified from the following.
1. Monthly searches of a number of major healthcare
databases: MEDLINE, EMBASE, CINHAL, PsycINFO and
LILACS.
2. Monthly searches of a number of trial registers: meta
Register of Controlled Trials (mRCT); Umin Japan Trial
Register; World Health Organization International Clinical
Trials Registry Platform (ICTRP/WHO) portal (which covers
ClinicalTrials.gov; ISRCTN; Chinese Clinical Trials Register;
German Clinical Trials Register; Iranian Registry of Clinical
Trials and the Netherlands National Trials Register, plus others).
3. Quarterly searches of the Central Register of Controlled
Trials (CENTRAL) in The Cochrane Library.
4. Six-monthly searches of a number of grey literature sources:
ISI Web of knowledge Conference Proceedings; Index to Theses;
Australasian Digital Theses.
To view a list of all sources searched for ALOIS see About ALOIS
on the ALOIS website.
We ran additional separate searches inmany of the above sources to
ensure that the most up-to-date results were retrieved. The search
strategy that was used for the retrieval of reports of trials from
MEDLINE (via the OvidSP platform) can be seen in Appendix
1. These searches were completed in January 2013.
Searching other resources
We searched identified citations for additional trials and contacted
the corresponding authors of identified trials for additional ref-
erences and unpublished data. We scanned the reference lists of
identified publications and all review papers that were related to
depression and anxiety in dementia.
Data collection and analysis
We used standard methodological procedures expected by The
Cochrane Collaboration.
Selection of studies
Two review authors (VO, AQ) worked independently to iden-
tify RCTs that met the inclusion criteria. We discussed any dis-
agreements with the fourth author (MO) and third author (AS).
We excluded those studies that clearly did not meet the inclusion
criteria and obtained copies of the full texts of potentially rele-
vant references. We documented reasons for exclusion of studies.
Where necessary, we requested additional information from study
authors.
Data extraction and management
Two review authors (VO, AQ) extracted data independently using
a standardized data extraction form, which was piloted before use.
We contacted the authors of the primary trials if there were doubts
regarding missing data or methodological details of the trial. The
extracted information included data on methods, participants, in-
terventions, outcomes and results.
Methods: in relation to the methods used, data were extracted on
methodologies used for randomisation.
Participants: items related to participant characteristics were num-
ber, gender and age of participants, diagnostic criteria, and other
items of importance (exclusion criteria for patients).
Interventions: data relevant to the interventions used were specifics
of duration, intensity, type, and frequency of the psychological
intervention.
Outcomes: primary outcomes included ratings of anxiety and de-
pression. Secondary outcomes included measures of quality of life,
daily activity level (for exampleADLs), and frequency of neuropsy-
chiatric symptoms (e.g. NPI) for the patient. Secondary outcome
measures for the caregiver were quality of life and experience of
caregiver burden.
Results: summary statistics for eachRCTwere themean value of the
outcome measurements in each intervention group, standard de-
viations of the outcomemeasurements in each intervention group,
and the number of participants for whom the outcome was mea-
sured in each intervention group (in the case of continuous data).
Assessment of risk of bias in included studies
We employed the recommended approach by theCochrane Hand-
book for Systematic Reviews of Interventions for assessing risk of bias.
This addresses six specific domains: sequence generation, alloca-
tion concealment, blinding, incomplete outcome data, selective
reporting and other issues. In each domain, the review authors
worked independently in relation to input of entries in a risk of
bias table and we resolved differences by discussion or by appeal
to a third author (MO or AS). In cases where no information was
available in order to make a judgment, this was explicitly stated.
We summarised results in both a ’Risk of bias’ graph and a ’Risk
of bias’ summary. Results of the meta-analysis were interpreted by
considering the findings with respect to risk of bias.
Measures of treatment effect
For five of the analyses conducted, the studies that were pooled
used different scales, therefore the absolute mean difference di-
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vided by the standard deviation (the standardised mean difference)
was used. We did not identify any binary outcomes.
Unit of analysis issues
We did not include any cluster randomised trials or trials with
multiple treatment groups.
Dealing with missing data
We recorded missing data and dropout rates for each individual
RCT.We reported the number of participants included in the final
analysis as a proportion of all participants in the study.
Assessment of heterogeneity
We assessed heterogeneity between the included studies by using
a formal statistical test of the significance of heterogeneity (Chi2
test) (Deeks 2001).We consideredP values <0.10 to be statistically
significant. We quantified heterogeneity by using the I2 statistic.
Assessment of reporting biases
See sections below.
Data synthesis
We used a fixed-effect model to present overall estimated effects.
We used ReviewManager 5 in order to conduct the meta-analysis.
We used standardised mean differences in some of the analyses as
not all studies used the same outcome scale.
Subgroup analysis and investigation of heterogeneity
Therewas little heterogeneity between studies.Wedidnot conduct
any subgroup analyses.
Sensitivity analysis
We did not conduct any sensitivity analyses.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
Results of the search
A total of 349 references were identified through database search-
ing, which was conducted fromDecember 2011 to January 2013.
Three additional references were identified by the authors via other
sources. After removal of duplicates and clearly irrelevant articles,
62 full text records were retrieved. Of these 62 references, 22 could
be excluded at this stage as not being relevant, leaving 40 full text
references to be fully assessed for eligibility. Of these, a total of
32 studies were excluded as they did not meet the review crite-
ria (see Characteristics of excluded studies), one study is ongoing
(see Characteristics of ongoing studies) and one study is awaiting
classification (see Characteristics of studies awaiting classification).
Thus six studies were found to be eligible for inclusion. See Figure
1 for a PRISMA flow diagram detailing the search process.
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Figure 1. Study flow diagram.
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Included studies
Six studies met the inclusion criteria for this review: Burgener
2008; Burns 2005; Spector 2012; Stanley 2012; Tappen 2009 and
Waldorff 2012 (see Characteristics of included studies). All six tri-
als were included in the first analysis on effects of psychological
treatment on depression. For the second set of analyses two stud-
ies (Spector 2012; Stanley 2012) contributed to evaluating the ef-
fects of psychological treatment on anxiety. Three of the studies
(Spector 2012; Stanley 2012; Waldorff 2012) were included in
the third analysis on effects of self-rated quality of life. Two stud-
ies (Spector 2012; Waldorff 2012) were included in the analysis
on carer-rated quality of life, and ADLs (Burns 2005; Waldorff
2012). Data from Spector 2012 and Waldorff 2012 were pooled
in the analyses on effects of treatment on neuropsychiatric symp-
toms. A total of four studies contributed to the analysis for effects
of treatment on cognition (Burgener 2008; Burns 2005; Spector
2012; Waldorff 2012). Data from Spector 2012, Stanley 2012
and Waldorff 2012 were pooled for the final analysis on effects of
carer depression. All the included studies were published in En-
glish. Authors were contacted for clarification of the procedures of
randomisation, blinding and additional data. The included stud-
ies varied in the following: (1) participant characteristics such as
setting, severity of dementia or cognitive function; (2) number of
treatment sessions and duration of the psychological intervention;
(3) type of psychological treatment evaluated; (4) control group
characteristics; and (5) outcome measures. We contacted five au-
thors for additional data and information in relation to the in-
cluded studies. Three authors responded to the call for provision
of additional data or information. An overview of ’Characteristics
of included studies’ can be seen in Table 1.
Design
All six studies were randomised controlled trials (RCTs) and eval-
uated the effectiveness of a psychological intervention aimed to
reduce depression or anxiety, or both, or to improve mood and
well-being in people with dementia.
Sample size
There were 43 participants in Burgener 2008, 40 in Burns 2005,
50 in Spector 2012, 32 in Stanley 2012, 36 in Tappen 2009, and
330 in Waldorff 2012.
Settings
Burns 2005 and Spector 2012 were conducted in the UK and
recruited patients living in the community. Stanley 2012 recruited
participants from primary care outpatient clinics and community
day centres specializing in dementia care, in Houston, Texas.
Tappen 2009 was based at a large long-term care facility inMiami,
Florida. Waldorff 2012 was conducted in community settings in
the Frederiksberg and Copenhagen municipalities in Denmark.
Burgener 2008 was conducted in the USA and did not specify the
setting.
Participants
In Burgener 2008 all patients had a confirmed diagnosis of de-
mentia (Alzheimer’s, Lewy body, vascular, frontal lobe, or mixed
dementia) and a score of < 2.0 on the Clinical Dementia Rating
Scale (Hughes 1982) indicative of mild disease stage. Diagnostic
criteria used for the presence of dementia were not specified. Au-
thorsmentioned that all participantswere screenedusing theMini-
Mental State Examination (MMSE) and the Clinical Dementia
Rating (CDR). Participants were on average 77 years of age and
53% were male. There were no differences in the two groups at
baseline in terms of demographic characteristics, cognitive func-
tioning, physical and behavioral measures, or baseline morbidity.
The mean MMSE (Folstein 1975) scores were 24.8 and 22.9 for
the treatment and control groups respectively.
In Burns 2005, all patients had a diagnosis of Alzheimer’s Disease
according to the National Institute of Neurological and Commu-
nicative Diseases and Stroke/Alzheimer’sDisease and Related Dis-
orders Association (NINCDS-ADRDA) criteria McKhann 1984,
a CDR of 1 (Morris 1993) indicating mild dementia and a score
of 15 or above on the MMSE (Folstein 1975). Participants lived
in their own home, they had a mean age of 75 years and 52%
were male. A total of 40% of the sample were on antidepressants
and approximately two thirds of each group (37% of total sam-
ple) were on cholinesterase inhibitor drugs. The mean MMSE
(Folstein 1975) scores were 24.4 and 21.5 for the treatment and
control groups respectively.
Spector 2012 recruited a total of 50 people with dementia who
were living in the community (60% females). All participants had
a diagnosis of dementia in the mild to moderate range according
to DSM-IV criteria. The mean age was 78 years, and the MMSE
mean score was 20.9. Approximately half of the sample had a rat-
ing of 1 on the CDR, with the remaining participants scoring 0.5
or 2. Clinical anxiety was determined by a score of 11 or above
on the Rating Anxiety in Dementia scale (RAID). The mean anx-
iety rating (RAID) at baseline was 19.7, and the mean depression
rating (Cornell Scale for Depression in Dementia (CSDD) was
15.9. Patients with a comorbid psychiatric disorder, challenging
behaviour, learning disability or severe physical illness that could
impact on participation were excluded.
In Stanley 2012, anxiety was indicated by a positive response to at
least one of three screening questions from theNPI-Anxiety (NPI-
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A) subscale (Cummings 1994). Participants had a diagnosis of de-
mentia (confirmed by the patient’s medical provider), an NPI-A
≥ 4, and a CDR score of 0.5 to 2.0. Patients with a primary psy-
chiatric diagnosis of major depression, psychosis, bipolar disorder,
suicidal intent, or verbal or physical aggression were excluded. Par-
ticipants had a mean age of 78 years and 59% were female. Most
of the sample had AD, with the remaining participants having a
diagnosis of dementia with Lewy bodies (DLB), vascular demen-
tia (VaD), or dementia not otherwise specified. Nearly half of the
sample scored a CDR of 0.5 or 1, and 75% were prescribed at
least one psychotropic medication. A total of 43.8% had a diag-
nosis of GDA, 18.8% a diagnosis of other anxiety disorder, 43.8%
comorbid anxiety and depression, 34.4% no diagnosis and 3.1%
a depression diagnosis.
For the Tappen 2009 study, all patients were nursing home res-
idents with probable AD using the NINCDS-ADRDA criteria
(McKhann 1984) and a MMSE score (Folstein 1975) of 25 or
less (range 0 to 25). The length of stay in the facility ranged from
160 to 1750 days, with a mean of 561 and 595 days for the treat-
ment and control groups respectively (this difference was not sig-
nificant). Mean age was 87 years, with the treatment group being
younger compared to the control group. The meanMMSE of the
treatment group was 10.60, and 12.26 for the control group (not
significant).
Waldorff 2012 included community-dwelling patients (age ≥ 50
years, mild dementia with MMSE ≥ 20) with mild recently diag-
nosed dementia. All participants had a diagnosis of probable AD,
mixed AD or DLB established in the last 12 months, meeting the
DSM-IV criteria, NINCDS-ADRDA criteria (McKhann 1984)
for probable AD or the McKeith 1996 criteria. The mean age for
participants was 76 years and 45.8% were male. Of the 330 pa-
tients, 72% had AD, 25% hadmixed AD and VaD, and 3%DLB.
Patients received antidementia treatment which was reported as ei-
ther cholinesterase inhibitors (93%) or memantine (1%). Patients
with severe somatic or psychiatric comorbidity, those residing in a
nursing home at baseline, or those with a diagnosis of frontotem-
poral dementia were excluded. The meanMMSE of the treatment
group was 24.0, and 24.1 for the control group.
Psychological interventions
The type of psychological intervention varied from therapeutic
counselling (therapeutic conversation, counselling with education
and support) to CBT (combined with social support and Tai Chi
exercises, CBT aimed at reducing anxiety) to interpersonal psy-
chodynamic therapy. Burgener 2008 tested the effectiveness of a
multimodal intervention consisting of Tai Chi exercises, CBT and
support group participation compared to an attention-control ed-
ucational program. Tai Chi exercises consisted of strength and bal-
ance training adapted for people with dementia, with components
from traditional Taiji training (that is form choreography, dynamic
Qigong, and standing and sitting meditation). Instructors had re-
ceived extensive training in Tai Chi, with a minimum of five years
of practice. TheCBT intervention included both small groups and
individual therapy sessions (based on individual needs). Each ses-
sion lasted for 90 minutes and used standard CBT treatments for
mood following guidelines by Teri 1991. Cognitive strategies were
challenging dysfunctional cognitions, developing positive coping
skills to manage the effects of the disease, and enhancing personal
control. Behavioural strategies included participating in pleasant
activities thereby increasing success. Social workers certified in in-
dividual and family therapy conducted theCBT intervention. The
support group focused on coping and problem-solving in relation
to the effects of dementia and developing relationships with others
sharing similar experiences, using the group structure for support
groups outlined by Yale 1995.
Burns 2005 evaluated the effects of a brief psychodynamic in-
terpersonal therapy program versus treatment as usual (consist-
ing of general advice about diagnosis and treatment of dementia
with out-patient review). Interpersonal psychodynamic therapy
was provided (six sessions in total) by an experienced psychother-
apist and was based on the conversational model of psychotherapy
(Hobson 1985) adapted for people with AD (Brierley 2003). The
principal aim of the therapy was identifying interpersonal conflicts
or difficulties causing emotional distress. Emphasis was placed on
improving interpersonal relationships. Carers were also involved
in the treatment, which included the therapist listening to their
needs and informing them of therapeutic progress (10 minutes of
the 50-minute sessions). The intervention confirmed adherence
to the model (Shapiro 1993), where adherence was evident by
high scores on psychodynamic interpersonal therapy and generic
subscales and low scores on the CBT scale.
Spector 2012 evaluated a CBT intervention for people with anxi-
ety and dementia (10 sessions in total). The intervention included
identifying and practicing strategies for feeling safe, challenging
negative thoughts, and incorporating calming thoughts and be-
havioural experiments with the use of cue cards. The degree to
which cognitive and behavioural elements were used varied be-
tween the people with dementia and clinicians were provided with
specific guidelines on how to adapt the themes of each session to
each individual. In between the CBT sessions telephone support
was offered, which included answering questions and encourag-
ing ongoing work. Other components included building a col-
laborative relationship with the therapist and socialisation to the
CBT model. Carers were encouraged to be involved by support-
ing the person with dementia in implementing CBT strategies,
such as applying the therapy content to everyday life and consol-
idating learned skills. The intervention was delivered by clinical
or counselling psychologists with experience working with people
with dementia. Participants in the control group received standard
treatment available to people with anxiety and dementia, which
included either medication or no treatment.
Stanley 2012 evaluated the Peaceful Mind program, a CBT-based
intervention targeting anxiety in dementia, involving self-moni-
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toring for anxiety, deep breathing and optional skills (coping self-
statements, behavioural activation, and sleep management). Pa-
tients’ learned skills and the collaterals served as coaches (in weekly
skill learning, serving as a coach for the patients’ practice be-
tween sessions). The intervention was provided by two masters-
level graduate student clinicians and a predoctoral intern over six
months. The program included up to 12 weekly in-home ses-
sions (lasting 30 to 60 minutes) over the initial three months and
up to eight brief telephone booster appointments during months
three to six. Modification from traditional CBT included repeated
instructions, more in-session practice, spaced retrieval, reminder
cues, and simplified session summaries.Materials were provided to
patients and their collaterals (Paukert 2010), including handouts
to address communication, dementia education and stress reduc-
tion for the collaterals (available for use as needed). Participants
assigned to usual care received diagnostic feedback but did not
receive any additional study contact other than the scheduled as-
sessments. A random sample of 20% of the sessions were reviewed
by an independent treatment integrity rater indicating adequate
adherence and competency.
InTappen 2009 the intervention consisted ofmodified counselling
sessions (therapeutic conversation), a psychotherapeutic approach
modified for AD (Tappen 1997; Tappen 2001). The goals of thera-
peutic conversation were reducing anxiety, forming and maintain-
ing supportive relationships, and providing an opportunity for the
individual to express his or her feelings, in line with the theory of
Interpersonal relations by Peplau 1991. The intervener was a grad-
uate nursing student trained to provide the intervention. Treat-
ment implementation was monitored by the investigator meeting
with the intervener for supervision. The control group received
usual care provided by the staff of the long-term care facility.
In Waldorff 2012 the intervention comprised a multifaceted
and semi-tailored intervention which included a counselling pro-
gramme (including telephone counselling and support), educa-
tional course, written information supporting patients and care-
givers during the initial months after a diagnosis had been estab-
lished in order to support the counselling sessions, and logbooks.
The objective of the intervention was to prevent depression and
impairment of quality of life in patients and caregivers, by fo-
cusing on positive resources, intact functions and retaining skills
(for patients). Counselling sessions aimed towards preventing or
reducing depressive symptoms, and were based on constructivist
principles (Peavey 1997). The teaching course provided informa-
tion about living and coping with dementia, and served as a ref-
erence guide after completion of the intervention. Outreach tele-
phone counselling was provided to ensure regular contact and to
follow up on issues discussed during the individual counselling
sessions, or issues relevant to individual participants. Patients and
caregivers were each supplied with a logbook encouraging them to
make notes about their daily life and to prepare for the counselling
sessions (optional). The control group did not receive the inter-
vention, however, as both groups of participants were interviewed
about symptoms and were informed about available support pro-
grammes it is likely that the control group received services above
the level of usual care, but no structured intervention was offered.
Length, number and duration of psychological interventions
The duration of the psychological intervention varied from six
weeks to 12 months, with the length of the sessions varying from
30 to 90 minutes.
In Burgener 2008, Tai Chi exercises consisted of one-hour classes
offered three times weekly for 20 weeks (although the duration
of the intervention was 40 weeks, comparison data between the
treatment and control groups were available for 20 weeks only).
Qigong relaxation exercises encompassed approximately 30 min-
utes of the 60-minute class. The CBT intervention was conducted
bi-weekly for 20 weeks, lasting 90 minutes. The support group
met bi-weekly, alternating with the CBT group, lasting also for 90
minutes.
In Burns 2005 patients received six sessions of psychodynamic
interpersonal therapy, with the duration of the intervention being
sixweeks. The length of the sessionswas 50minutes each, of which
10 minutes were spent with the carer.
In Spector 2012 participants received a total of 10 sessions of CBT,
with the duration of the treatment being 15 weeks. The length
of each CBT session was 60 minutes. Participants were offered
telephone support in between the sessions.
In Stanley 2012 participants received 12 weekly in-home sessions
during the initial three months and up to eight brief telephone
sessions during months three to six, with the duration of the in-
tervention being six months. Each session lasted 30 to 60 minutes
and was provided at the participant’s home (Paukert 2010).
InTappen 2009 therapeutic conversationwas provided three times
a week, with a total duration for the intervention of 16 weeks,
with each session lasting 30 minutes.
In Waldorff 2012, the intervention was provided for a duration of
eight to 12 months. Counselling sessions comprised six sessions in
total with an additional optional network session (that is family).
The educational course was composed of a total of five sessions
(two hours each). Telephone counselling was provided approxi-
mately five to eight times within three- to four-week intervals.
Compliance was defined as patients who had participated with
their caregivers in at least three counselling sessions and three ed-
ucational (teaching) sessions.
Adherence to psychological treatment
Burgener 2008 reported attendance at exercise, CBT, and support
sessions. For the Tai Chi classes, 75% of participants attended
all three sessions weekly, with 90% attending at least two of the
three weekly sessions. The authors stated that attendance rates for
the CBT and support groups were similar. In the study by Burns
2005 no adherence data were reported, but the authors reported
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that one session from each individual therapy was rated for ad-
herence Shapiro 1993, with the intervention showing high scores
on the model used (that is psychodynamic interpersonal therapy).
In Spector 2012 a total of 56% of those in the treatment group
completed all sessions, and 28% participated in more than half of
the sessions. Stanley 2012 reported that the average number of in-
person sessions was eight (average duration of completed sessions
was 47 minutes). Participants completed an average of 3.5 home-
work exercises per week and spent an average of 81 hours per week
with the collateral. Between months three and six, dyads received
an average of five of a possible eight telephone booster calls (66%).
Participants reported using breathing most often (58%), followed
by behavioural activation (50%) and calming thoughts (41%). In
Tappen 2009 treatment implementation was monitored.Waldorff
2012 defined compliance as the rate of adherence to the major
parts of the intervention (that is participating in at least half of the
counselling and educational teaching sessions). A total of 72% in
the intervention group completed the intervention.
Outcomes
All studies reported outcomes immediately after the intervention
was finished, with the exception of the study by Burgener 2008
in which outcome data for the control group at the end of the
intervention were not available. The following time points were
included in the present review: for Burgener 2008 depression and
cognition were measured at 20 weeks; for Burns 2005 depression,
ADLs and cognition were measured at six weeks (end of treat-
ment); for Spector 2012 depression, anxiety, self- and carer-rated
quality of life, neuropsychiatric symptoms, cognition and carer
depression were measured at 15 weeks (end of intervention). We
extracted data fromStanley 2012 for depression, anxiety, self-rated
quality of life, and carer depression at six months (end of interven-
tion); for Tappen 2009 depression at 16 weeks (end of treatment),
and for Waldorff 2012 depression, self- and carer-rated quality of
life, ADLs, neuropsychiatric symptoms, cognition and carer de-
pression measured at 12 months (end of treatment).
Depression
Depression was measured in all studies using a standardised in-
strument. Burgener 2008 measured depression using the Geriatric
Depression Scale (GDS) (Yesavage 1983), at baseline and at 20
weeks. Scores in this scale (15-item GDS) range from 0 to 15,
with higher scores indicating greater depression. Data from the
control group at 40 weeks were not available, therefore outcome
data at 20 weeks were included in the analysis. Stanley 2012 used
the 30-item GDS scale (Yesavage 1983) (range of scores 0 to 30,
higher scores indicating greater depression) to measure depression
at baseline, three and six months. Burns 2005, Spector 2012 and
Waldorff 2012 used the Cornell Scale for Depression in Demen-
tia (Alexopoulos 1988). Burns 2005 measured depression at base-
line, six weeks and three months; Spector 2012 at baseline, 15
weeks and six months; whereas Waldorff 2012 measured depres-
sion levels at baseline, six and 12 months. For this scale scores
range from 0 to 38, with higher scores indicating higher levels
of depression. Tappen 2009 measured depressive symptoms with
the Montgomery-Asberg Depression Rating Scale (Montgomery
1979), which is used less often in people with dementia, mea-
sured at baseline and at 16 weeks (rated by a psychiatrist, a general
practitioner and a nurse). In this scale, higher scores indicate in-
creasing depressive symptoms (range of scores 0 to 50). Note that
Spector 2012 also measured self-reported depression for people
with dementia with the Hospital Anxiety and Depressions Score
(HADS), however these data were not included in the analyses.
Tappen 2009 used theDementiaMoodAssessment Scale (DMAS)
(Sunderland 1988), which measures general mood as opposed to
depression, including only items 1 to 17 for the analysis, and
the Alzheimer’s Disease and Related Disorders (AD-RD) Mood
Scale (Tappen 2008), which represents both positive and negative
moods, and specifically feelings of spirituality, content, hostility,
apathy and sadness. These outcome measures were not included
in the analysis on the basis that they do not specifically measure
feelings of depression or anxiety but negative or positive mood in
general.
Anxiety
Both Spector 2012 and Stanley 2012 measured anxiety with the
Rating Anxiety in Dementia (RAID) (Shankar 1999). Scores on
this 18-item, clinician-rated scale range from 0 to 54, with higher
scores indicating higher levels of anxiety. Spector 2012 measured
anxiety at baseline, 15 weeks and six months; whereas Stanley
2012 at baseline, three and six months. In Spector 2012 self-rated
anxiety by people with dementia was measured with the HADS
(Zigmond 1983) at baseline, 15weeks and sixmonths. TheHADS
is a 14-item self-report questionnaire designed to assess general-
ized anxiety (a seven-item subscale), with scores ranging from 0
to 21 (higher scores indicating greater symptoms). Stanley 2012
measured self-ratings of anxiety by people with dementia with the
Geriatric Anxiety Inventory (GAI) (Pachana 2007) at baseline,
three and six months. Scores on the GAI range from 0 to 20, with
higher scores indicating greater anxiety. Stanley 2012 measured
anxiety based on collateral report using the Neuropsychiatric In-
ventory-Anxiety (NPI-A) subscale (Cummings 1994) at baseline,
three and six months. Scores on this seven-item scale range from
0 to 12, with higher scores indicating higher levels of anxiety.
Quality of life
Spector 2012, Stanley 2012 and Waldorff 2012 measured patient
quality of life (self-ratings) using the Quality of Life in Alzheimer’s
Disease (QOL-AD) (Logsdon 1999) in which scores range from
13 to52,with higher scores indicating better quality of life. Spector
2012measured quality of life at baseline, 15weeks and sixmonths;
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Stanley 2012 at baseline, three and six months; andWaldorff 2012
at baseline, six and 12 months. Both Spector 2012 and Waldorff
2012 used the same scale to measure carer-rated quality of life
using the QOL-AD.
Activities of daily living (ADL)
Burns 2005 measured ADL using the Bristol Activities of Daily
Living Scale (Bucks 1996), where higher scores indicate lower
levels of ADL (scores range from 0 to 60). Waldorff 2012 used the
Alzheimer’s Disease Cooperative Study - Activities of Daily Living
scale (ADSC-ADL) (Galasko 1997). The ADSC-ADL Inventory
total score ranges from 0 (lower functioning status) to 78 (higher
functioning status).
Neuropsychiatric symptoms
Both Spector 2012 and Waldorff 2012 measured neuropsychi-
atric symptoms. Spector 2012 used the Neuropsychiatric Inven-
tory (NPI) (Cummings 1994) at baseline, 15weeks and sixmonths
(12-item NPI). Scores on the NPI range from 0 to 144 with
higher scores indicating greater behavioural disturbance. Waldorff
2012 used the NPI-Questionnaire (NPI-Q) (Cummings 1994)
with scores ranging from 0 to 28, with higher scores indicating
higher levels of symptoms. Waldorff 2012 measured neuropsychi-
atric symptoms at baseline, six and 12 months.
Cognition
Burgener 2008, Burns 2005, Spector 2012 and Waldorff 2012
measured cognition before and after the intervention. All four
trials used the MMSE (Folstein 1975), with range of scores from
0 to 30, with lower scores indicative of greater impairments in
cognitive function.
Other patient outcomes
Burns 2005 provided data (detransformed log means) on be-
havioural problems (carer’s reaction) measured by the Revised
Memory and Behaviour Problems Checklist (Teri 1992). Stanley
2012 measured self-reported experience of worry using the Penn
State Worry Questionnaire-Abbreviated (PSWQ-A) (Crittendon
2006).Waldorff 2012 provided data on proxy (carer)-rated quality
of life using the EQ-5D (EuroQoL 1990). Spector 2012 used the
Quality of the Caregiver Patient Relationship (QCPR) (Spruytte
2002) to measure patient ratings of the quality of the caregiving
relationship.
Caregiver outcomes
Spector 2012 measured carer depression at baseline, 15 weeks and
six months, using the HADS. Stanley 2012 measured depression
in carers using the Patient HealthQuestionnaire (PHQ-9) at base-
line, three and six months. Scores on the PHQ-9 range from 0
to 24 with higher scores indicating higher levels of depression.
Waldorff 2012 measured carers’ depressive symptoms using the
GDS (Yesavage 1983). Although Burns 2005 used the Beck De-
pression Inventory (BDI) (Beck 1961) to measure depression in
carers, data were not provided.
Other caregiver outcomes
Waldorff 2012 measured health-related quality of life in carers us-
ing the EQ-5D (EuroQoL 1990). Spector 2012 measured carer
ratings of the quality of the caregiving relationship using the
QCPR (Spruytte 2002). Spector 2012 measured caregiver distress
using theNPI (Cummings 1994), whereas Stanley 2012 measured
distress specifically related to anxiety symptoms using the NPI-A
subscale (Cummings 1994).
Excluded studies
We excluded a total of 32 studies. A total of 24 were excluded be-
cause the intervention did not meet the criteria for a psychological
intervention. In six studies participants did not fulfil the criteria
for a diagnosis of dementia or MCI. Two studies were excluded as
they were not conducted as RCTs.
Studies not meeting ’Types of participants’ criteria
In the studies by Abraham1992,Hyer 2008, Kiosses 2010, Kiosses
2011, Konnert 2009 and Yesavage 1981 participants did not fulfil
the criteria for a diagnosis of dementia.
Studies not meeting ’Types of interventions’ criteria
In the following studies the intervention did not meet the criteria
for a psychological intervention: Beck 2002; Kolanowski 2011;
Lichtenberg 2005; Vespa 2002 (psychosocial activities); Brodaty
2003; Hinchliffe 1997: McSweeney 2012 (case management);
Finnema 2005 (emotion-oriented care); Fischer-Terworth 2011
(CBT-based environmental intervention); Fossey 2006; Proctor
1999; Selbaek 2010 (staff training); Garland 2007 (simulated
family presence); Lam 2010 (CBT-based occupational therapy),
Logsdon 2010 (social support), Mittelman 1996 (individual or
family counselling for carers), Onor 2007; Dartigues 2008 (cog-
nitive intervention); Teri 2003; Prick 2011 (exercise and caregiver
training); Rovner 2012 (behavioural activation for cognitive de-
cline); Helcer 2012; Kurz 2012 (cognitive training with CBT);
Laakkonen 2012 (self management).
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Studies not meeting ’Types of studies’ criteria
Two studies were excluded as they were not conducted as RCTs
(Cheston 2003; Joosten-Weyn Banningh2011).
Several of those studies excluded on the basis of the criteria above
additionally were not conducted as an RCT: Fischer-Terworth
2011; Garland 2007; Selbaek 2010; Yesavage 1981; or had
a control or comparison group receiving an active interven-
tion: Dartigues 2008 (psychoeducative group for carers); Fischer-
Terworth 2011 (occupational therapy); Helcer 2012 (memory
training); Kiosses 2010; Kiosses 2011 (supportive therapy); Kurz
2012 (occupational therapy or carer counselling); Lam 2010 (oc-
cupational therapy); Rovner 2012 (supportive therapy); Yesavage
1981 (cognitive training).
Risk of bias in included studies
See Figure 2 for a ’Risk of bias’ graph which shows assessments
about each risk of bias item presented as percentages across all
included studies (Characteristics of included studies), and Figure
3 for a summary of our judgments about each risk of bias item for
each included study.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
All studies reported use of randomisation, however detailed de-
scriptions varied between the studies. Burns 2005, Spector 2012
andWaldorff 2012 provided an adequate description of allocation
concealment and random sequence generation and were classified
as having low risk of bias in this domain. For Stanley 2012 random
sequence generation was specified but there was no information
about allocation concealment, therefore the study was classified as
having unclear risk in this domain. Burgener 2008 and Tappen
2009 did not describe how allocation concealment and random
sequence generation were performed and were therefore classified
in this domain as having unclear risk of bias.
Blinding
In Waldorff 2012 raters were blind to treatment allocation and
the authors stated that the personnel co-ordinating and offering
the treatment were not employed by the same institution as the
raters (low risk of bias). Burgener 2008 communicated that the
assessors were blind in some but not all assessments and this study
was therefore classified as unclear in this domain. Burns 2005 did
not report details of blinding and was also classified as unclear (no
further information from the authors was provided). In Spector
2012, Stanley 2012 and Tappen 2009 raters were blind to alloca-
tion so the studies were classified as at low risk of detection bias.
No information was provided for blinding of personnel, so in the
domain of performance bias Burgener 2008, Burns 2005, Spector
2012, Stanley 2012 and Tappen 2009 were classified as having
unclear risk of bias in this domain.
Incomplete outcome data
Burgener 2008 and Tappen 2009 reported attrition for both the
treatment and the control groups, and Burns 2005, Spector 2012
and Stanley 2012 reported attrition and specified the use of inten-
tion-to-treat analyses, so all five studies were classified as low risk.
Waldorff 2012 also specified use of intention-to-treat analyses and
reported details of attrition, so we classified the study as low risk.
Considering the characteristics of the population, attrition in the
studies was relatively small, with zero attrition reported in one
study (Burns 2005).
Selective reporting
Burgener 2008, Spector 2012, Stanley 2012, Tappen 2009 and
Waldorff 2012 reported all pre-specified outcomes and were clas-
sified as at low risk of bias. Burns 2005 reported all outcomes
for patients but did not report depression scores for family carers
(BDI) (Beck 1961). This study was classified as at high risk of bias
in this domain.
Other potential sources of bias
No other apparent bias was identified in each of the studies.
Effects of interventions
See: Summary of findings for the main comparison
Psychological treatment compared to treatment as usual for
depression and anxiety in dementia and mild cognitive
impairment
We were able to pool data from all six studies (Burgener 2008;
Burns 2005; Spector 2012; Stanley 2012; Tappen 2009; Waldorff
2012) for depression. When testing the effects of psychologi-
cal treatment on anxiety only, Spector 2012 and Stanley 2012
contributed data. Data from three (Spector 2012; Stanley 2012;
Waldorff 2012) and two studies (Spector 2012; Waldorff 2012)
were pooled for self-rated and carer-rated patient quality of life re-
spectively. Data from Burns 2005 andWaldorff 2012 were pooled
for testing the effects of the psychological treatment on ADL.
Spector 2012 and Waldorff 2012 contributed data on effects on
neuropsychiatric symptoms. Data from Burgener 2008, Burns
2005, Spector 2012 and Waldorff 2012 were pooled for analyses
on effects on cognition. No evidence of heterogeneity was detected
in the pooled studies, using the Chi² test. The final analysis in-
cluded pooled data fromSpector 2012, Stanley 2012 andWaldorff
2012 on effects of carer depression. In this analysis heterogeneity
was evident. A summary of the findings can be seen in the ’Sum-
mary of findings’ table 1.
Primary outcomes
Depression
The first meta-analysis on effects of psychological treatment on
patient depression included 439 participants (Analysis 1.1); results
favoured the psychological treatment (standardised mean differ-
ence (SMD) -0.22; 95% confidence interval (CI) -0.41 to -0.03)
in reducing depressive symptoms for people with dementia (Figure
4). This analysis was strongly influenced byWaldorff 2012, which
was the largest study, but there was little heterogeneity between
studies (I2 = 21%) (Figure 4).
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Figure 4. Forest plot of comparison: 1 Psychological treatment versus treatment as usual, outcome: 1.1
Depression.
Anxiety
Psychological treatment reduced clinician-rated anxiety measured
with the RAID (2 studies, 65 participants, MD -4.57; 95% CI
-7.81 to -1.32) (Analysis 1.2, Figure 5). However, there was no
effect on self-rated anxiety (2 studies, 65 participants, SMD 0.05;
95% CI -0.44 to 0.54) (Analysis 1.3, Figure 6) or carer-rated
anxiety measured with the NPI-A (1 study, 26 participants, MD
-2.40; 95% CI -4.96 to 0.16) (Analysis 1.4, Figure 7).
Figure 5. Forest plot of comparison: 1 Psychological treatment versus treatment as usual, outcome: 1.2
Anxiety RAID.
Figure 6. Forest plot of comparison: 1 Psychological treatment versus treatment as usual, outcome: 1.3
Anxiety (self ratings).
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Figure 7. Forest plot of comparison: 1 Psychological treatment versus treatment as usual, outcome: 1.4
Anxiety NPI-A.
Secondary outcomes
Patient quality of life
Psychological treatment had no effect on patient self-rated quality
of life (3 studies, 334 participants, MD 0.37; 95% CI -1.01 to
1.75) (Analysis 2.1, Figure 8) or on carer-rated patient quality of
life (2 studies, 313 participants, MD 0.66; 95% CI -0.77 to 2.09)
(Analysis 2.2, Figure 9).
Figure 8. Forest plot of comparison: 2 Psychological intervention versus treatment as usual, outcome: 2.1
Quality of life (self ratings).
Figure 9. Forest plot of comparison: 2 Psychological intervention versus treatment as usual, outcome: 2.2
Quality of life (proxy ratings).
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Activities of daily living (ADL)
Psychological treatment had no effect on ADL for people with
dementia (2 studies, 313 participants, SMD -0.13; 95% CI -0.35
to 0.09) (Analysis 2.3, Figure 10).
Figure 10. Forest plot of comparison: 2 Psychological intervention versus treatment as usual, outcome: 2.3
Activities of daily living.
Neuropsychiatric symptoms
Psychological treatment had no effect on neuropsychiatric symp-
toms (2 studies, 311 participants, SMD 0.06; 95% CI -0.16 to
0.28) (Analysis 2.4, Figure 11).
Figure 11. Forest plot of comparison: 2 Psychological intervention versus treatment as usual, outcome: 2.4
Neuropsychiatric symptoms.
Cognition
Psychogical treatment had no effect on cognition (4 studies, 381
participants, MD -0.80; 95% CI -1.70 to 0.11) (Analysis 2.5,
Figure 12).
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Figure 12. Forest plot of comparison: 2 Psychological intervention versus treatment as usual, outcome: 2.5
Cognition (Mini-Mental State Examination).
Carer’s depression
The final analysis showed that psychological treatment for people
with dementia had no effect on self-rated depressive symptoms for
carers (3 studies, 337 participants, SMD 0.07; 95% CI -0.14 to
0.29 Analysis 3.1, Figure 13). There was moderate heterogeneity
between studies in this analysis.
Figure 13. Forest plot of comparison: 3 Psychological intervention versus treatment as usual, outcome: 3.1
Carer depression.
Other outcomes
Behavioral problems
Burns 2005 used the Revised Memory and Behavior Problems
Checklist (Teri 1992), to measure carer’s reaction to behavioural
problems. We were not able to extract data for this outcome as
Burns 2005 did not provide sufficient data to be entered in the
meta-analysis (detransformed log means).
Adverse effects
None of the studies reported or described adverse events.
D I S C U S S I O N
Summary of main results
Six RCTs with a total of 439 participants (216 receiving psycho-
logical treatment, 223 receiving usual care or an attention and so-
cial contact control treatment) evaluated the efficacy of psycholog-
ical treatment in reducing depression in people with dementia and
met the inclusion criteria of the present review. The majority of
participants hadmild dementia. Results pooled from the six RCTs
showed that psychological treatments reduce depressive symptoms
in people with dementia. Data from two studies showed that psy-
chological treatments benefit people with dementia by reducing
anxiety symptoms measured with the RAID, a validated clinician-
rated tool. These results compare favourably with minimal or no
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benefits of pharmacological interventions in treating depression
in dementia (Bains 2009) and highlight the need for continuing
research in the area. The results may be particularly noteworthy
as in some studies the control group was enriched beyond usual
care, as opposed to standard care. Although both anxiety and de-
pression were primary outcomes for this review, only two studies
were identified that provided data for anxiety.
We found no effect of psychological treatment on any of the sec-
ondary outcomes, activities of daily living, self- and carer-rated
patient quality of life (QOL), neuropsychiatric symptoms, cog-
nition, or carers’ self-reported depressive symptoms. We did not
identify any trials of psychological treatment aimed at people with
MCI that met our inclusion criteria. The three studies identified
either did not employ an RCT design, participants had cognitive
impairment that was not specified according to established criteria
ofMCI, or the intervention that was evaluatedwas psychologically
based but specifically targeted cognitive decline.
The psychological interventions we included all targeted symp-
toms of anxiety and depression through a structured psychological
approach involving therapist and patient communication, which
included directly teaching people with dementia skills to reduce
anxiety and depression. Nevertheless, the included trials evaluated
a range of different psychological interventions and some used a
combination of treatments.
The length and duration of intervention also varied in the studies,
leading to differences in intensity and ’dosage’ of the psycholog-
ical treatments. A limitation of this review, therefore, is the sub-
stantial variation between studies in terms of the nature, duration
and intensity of the psychological therapy evaluated, which may
contribute to difficulties interpreting the data. Adherence to treat-
ment appears to have been good in all studies, but adherence in
randomised controlled trials may not translate into similar levels
of adherence in normal practice. The current review showed that
psychological interventions are of benefit for people with demen-
tia as they reduce both anxiety and depressive symptoms.
Overall completeness and applicability of
evidence
The studies that were included in the present review only par-
tially answer the research questions posed.We did not identify any
studies of people with MCI. We identified six studies of people
with dementia and were able to pool the results for depression,
anxiety, self- and carer-rated quality of life, ADL, neuropsychiatric
symptoms, cognition and carer self-reported depression. Results
for anxiety, QOL, ADL and neuropsychiatric symptoms were each
based on only two trials. We were not able to perform any sub-
group analyses.
Quality of the evidence
Only one of the studies was classified as low risk in all domains of
the Cochrane Collaboration ’Risk of bias’ tool (Waldorff 2012).
We classified the remaining five studies as being at unclear risk
of bias in certain domains, due to limitations such as uncertain-
ties about random sequence generation (Burgener 2008; Tappen
2009), allocation concealment (Burgener 2008; Stanley 2012;
Tappen 2009), blinding of participants and personnel (Burgener
2008; Burns 2005; Spector 2012; Stanley 2012; Tappen 2009) and
outcome assessment (Burgener 2008; Burns 2005). There was also
evidence of selective reporting in one trial (Burns 2005). Based on
the GRADE system, we have classified the quality of the evidence
as moderate for depression and low for clinician-rated anxiety, due
to the methodological limitations of the identified studies and the
limited number of trials.
Potential biases in the review process
We used a comprehensive and sensitive strategy to identify studies
that could potentiallymeet the inclusion criteria for this review.We
also contacted first authors of included studies as well as authors
of relevant references in order to identify further studies. Selection
of studies, data extraction, and assessments of risk of bias were
independently conducted by the first and second authors, and any
disagreement was resolved by contacting the authors of the studies
or the remaining two authors of this review. The present review
presents and discusses all outcomes described in the protocol that
were available for analysis, regardless of whether or not there was
statistical significance.
Agreements and disagreements with other
studies or reviews
The current review is distinctive in systematically analysing psy-
chological interventions to reduce anxiety or depression that are
conducted primarily with people with dementia or MCI, rather
than focusing on environmental changes or skills building for fam-
ily carers (Brodaty 2012). Previous reviews have concentrated on
the effectiveness of other interventions of a psychosocial nature
(including cognitive stimulation, cognitive rehabilitation, remi-
niscence, activities-based interventions etc.), which are not aimed
specifically at anxiety or depression (Livingston 2005; Olazarán
2010). These reviews do suggest that non-pharmacological inter-
ventions can be useful, and potentially cost-effective, in terms of
improving psychological outcomes (Livingston 2005; Olazarán
2010).
A U T H O R S ’ C O N C L U S I O N S
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Implications for practice
Evidence from sixRCTs shows that psychological treatments based
on a psychological model may benefit people with dementia by
reducing depressive symptoms. Evidence from two studies shows
that psychological treatments reduce symptoms of clinician-rated
anxiety for people with dementia. Psychological treatments for
people with dementia appear to be safe, with no adverse events
reported in the literature. This review concludes that psycholog-
ical treatments that primarily target depression and anxiety have
the potential to improve psychological well-being for people with
dementia.
Implications for research
Although many studies have been published examining the effec-
tiveness or feasibility of psychological treatments in reducing anx-
iety and depression in dementia, there are few well-designed ran-
domised controlled trials. The present review suggests that psycho-
logical treatments are of benefit to people with dementia as they
reduce depression and anxiety symptoms. Future RCTs should
adhere to the current highest standards of methodology and re-
porting, following the Consolidated Standards of Reporting Trials
(CONSORT) statement. They will be most helpful if they focus
on well-defined psychological approaches, rather than on multi-
modal approaches which combine a variety of treatments. Based
on the literature and the evidence from this review, psychological
treatments in dementia, and particularly CBT techniques, merit
further research. There is a need to study additional outcomes,
particularly quality of life. Research is also needed into psycholog-
ical treatments for people with depression andMCI, and to define
the effect of the severity of dementia on treatment efficacy. Future
RCTs should be conducted alongside cost-effectiveness studies.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Burgener 2008
Methods RCT
Repeated-measures randomised design
Outcomes at 20 weeks are included in this review
Control group: outcomes at 20 weeks only, delayed treatment group
(Control group was offered the intervention following the 20-week assessment)
Participants N = 43 (23M, 20F)
Confirmed diagnosis of dementia (Alzheimer’s, Lewy body, vascular, frontal lobe, or
mixed dementia)
A score of < 2.0 on the Clinical Dementia Rating Scale (early to early-middle disease)
Mean age = 76.95
Interventions Multimodal intervention consisting of Tai Chi exercises, cognitive-behavioral therapy
and support group
Tai Chi: strength and balance training and relaxation
CBT: challenging dysfunctional cognitions and developing positive coping skills
Support group: coping with dementia and positive problem solving
Duration of intervention: 20weeks (however complete intervention offered for 40weeks)
Control group received attention-control educational program
Outcomes Patient Outcomes
Cognitive function:
Mini-Mental State Examination (MMSE)
Physical functioning:
Single leg stance (SLS), Berg Balance Scale (BBS), and Cumulative Illness Rating Scale
(CIRS)
Depression:
Geriatric Depression Scale (GDS)
Other behavioral outcomes:
Rosenberg’s Self-Esteem Scale (SES)
Outcomes measured at 20 weeks and 40 weeks for the intervention group and at 20
weeks only for the control group
Notes Treatment duration 40 weeks
Tai Chi exercises: 1 hour classes offered weekly
Cognitive-behavioral therapy: 90 minute sessions offered bi-weekly
Support group: 90 minute sessions offered bi-weekly alternating with the CBT group
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Burgener 2008 (Continued)
Random sequence generation (selection
bias)
Unclear risk No details of randomisation described in
the study, insufficient information about
sequence generation
Allocation concealment (selection bias) Unclear risk No details of method of concealment de-
scribed to allow judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No evidence of blinding in the study, all
assessments and the intervention were con-
ducted at a neutral location
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Authors communicated that assessors were
blind in some but not all outcome assess-
ments
Incomplete outcome data (attrition bias)
All outcomes
Low risk 20% attrition for the treatment group and
24% for the control group, with reasons
reported
Selective reporting (reporting bias) Low risk All pre-specified outcomes reported
Other bias Low risk No other apparent bias
Burns 2005
Methods RCT
Participants N = 40 (21M, 19F)
Dementia diagnosis according to NINCDS-ADRDA criteria, a Clinical Dementia Rat-
ing (CDR) of 1 indicating mild dementia, MMSE score > 15
Living in own home with a carer with regular contact
Clinically stable (for the last 2 months) if on anti-dementia or psychotropic medication
Mean age = 75.8
Interventions Psychodynamic interpersonal therapy (improving social and interpersonal relationships,
identification of conflicts that cause or maintain emotional distress). Therapist also
spends time with carer (listening to their needs and informing them of therapeutic
progress)
Duration of intervention: 6 weeks
Control group described as standard treatment in AD, consisted of general advice re-
garding the diagnosis and treatment of dementia, with out-patient review
Outcomes Patient Outcomes
Cognitive function: Mini-Mental State Examination (MMSE)
Depression: Cornell Scale for Depression in Dementia (CSDD)
Other patient outcomes:
Bristol Activities of Daily Living (BADLS)
Clinician’s Interview-Based Global Impression of Change (CIBI)
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Burns 2005 (Continued)
Caregiver outcomes
Revised Memory and Behavior Problems Checklist (RMBPC) - Carers reaction
General Health Questionnaire (GHQ-12)
Beck Depression Inventory ((BDI-II) (scores on this measure not available)
Ways of Coping Checklist (WCCL)
Outcomes reported at 6 weeks and 3 months (only 6 week data included in the review)
Notes 6 sessions of psychodynamic interpersonal therapy of 50 minutes each over 6 weeks
NINCDS-ADRDA - National Institute of Neurological and Communicative Diseases
and Stroke/Alzheimer’s Disease and Related Disorders Association
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were allocated to one of the two groups using com-
puter-generated random numbers
Allocation concealment (selection bias) Low risk Computer generated random numbers were organised indepen-
dently
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information is provided
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information is provided about assessors
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analyses conducted
No attrition
Selective reporting (reporting bias) High risk One pre-specified outcome (Beck Depression Inventory for car-
ers) not reported
Other bias Low risk No other apparent bias
Spector 2012
Methods RCT not published but data are available
single-blind, multicentre, pilot RCT of CBT versus TAU for people with dementia
Participants N = 50 (20M, 30F)
Inclusion criteria:
1. Meet DSM-IV criteria for dementia in mild to moderate range, Clinical Dementia
Rating (CDR) score of 0.5, 1 or 2.
2. Clinical anxiety, as determined by a score of 11 or above on the Rating Anxiety in
Dementia scale (RAID)
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Spector 2012 (Continued)
3. Living in the community
4. Presence of a carer who is willing to participate in the therapy
5. Ability to understand and communicate in English
6. Willing to engage in therapy involving discussion of thoughts and feelings
Exclusion criteria:
1. Co-morbid psychiatric disorder (e.g. psychosis) or challenging behaviour (e.g. severe
agitation) likely to prevent engagement in therapy
2. Presence of a learning disability or severe physical illness that could impact on partic-
ipation
Mean age was 78.4 (SD = 7.0), and MMSE mean score was 20.9 (SD = 5.2). A total of
26.3% scored .5 on the CDR scale, 47.4% had a rating of 1, and 14.0% had a rating of
2. Mean anxiety rating (RAID) at baseline was 19.7 (SD = 6.0), and themean depression
rating (CSDD) was 15.9 (SD = 6.2)
Interventions CBT for people with anxiety and dementia
10 weekly sessions (60 minutes each) comprising of identifying strategies for feeling safe,
calming thoughts and behavioural experiments, with telephone contact offered between
sessions. The intervention was delivered by clinical or counselling psychologists, with
experience of working with people with dementia
Control group: standard treatment available to people with anxiety and dementia, in-
cluding medication or no treatment
Outcomes Primary outcomes
Rating Anxiety in Dementia (RAID)
Clinical Services Receipt Inventory (CSRI)
Secondary outcomes
Hospital Anxiety and Depression Scale (HADS)
Quality of Life-Alzheimer’s Disease (QOL-AD) (self and proxy ratings)
Neuropsychiatric Inventory (NPI)
Mini-Mental State Examination (MMSE)
Cornell Scale for Depression in Dementia (CSDD)
Quality of Caregiver and Patient Relationship (QCPR)
Caregiver outcomes
Hospital Anxiety and Depression Scale (HADS)
Outcomes reported at 15 weeks and 6months (only 15 week data included in the review)
Notes 10 sessions of CBT for anxiety of 60 minutes each for 15 weeks
ISRCTN46521766
Data were made available by the lead investigator but are not currently published
CBT - Cognitive Behavioural Therapy
TAU - Treatment as Usual
DSM-IV - Diagnostic and Statistical Manual of Mental Disorders, 4th edition
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Spector 2012 (Continued)
Random sequence generation (selection
bias)
Low risk The author communicated that random al-
location was performed with Stata’s ran-
dom allocation command with varying
block sizes of four and six
Allocation concealment (selection bias) Low risk Central allocation, randomisation con-
ducted by telephoning an independent ad-
ministrator within the Clinical Trials Unit
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information is provided
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All outcome measures administered by a
researcher blind to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and reasons reported by the au-
thor. Use of intention-to-treat analyses
Selective reporting (reporting bias) Low risk All pre-specified outcomes reported
Other bias Low risk No other apparent bias
Stanley 2012
Methods RCT
(randomisation in blocks of 4 or 6 stratified by CDR scores - 0.5, 1., or 2., completed
in SAS)
Participants n = 32 (13M, 19F)
Inclusion criteria
1) diagnosis of dementia (confirmed by the patient’s medical provider)
2) an NPI-A ≥ 4
3) CDR score of 0.5 to 2.0
Exclusion criteria
Ps with a primary psychiatric diagnosis of major depression, active psychosis, bipolar
disorder, active suicidal intent, recent verbal or physical aggression
Dementia diagnosis
AD (62.5%), DLB (3.1%), VaD (9.4%) and 25.0% dementia not otherwise specified
(NOS)
Principal DSM-IV Diagnoses
43.8% had a diagnosis of GAD, 18.8% a diagnosis of other anxiety disorder, 43.8%
comorbid anxiety and depression, 34.4% no diagnosis and 3.1% a depression diagnosis
A total of 46.9% of the sample scored a CDR of 0.5 or 1, and 75% were on at least one
psychotropic medication
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Stanley 2012 (Continued)
Interventions A cognitive-behavioral therapy-based intervention for anxiety in dementia, of 12 weekly
in-home based sessions and brief telephone sessions, involving self-monitoring for anx-
iety, deep breathing, and optional skills (coping self-statements, behavioral activation,
and sleep management). Carers were involved as coaches. Additional materials were pro-
vided on communication, education of dementia and stress reduction for collaterals
Control group receives usual care incorporating diagnostic feedback
Outcomes Patient outcomes
Depression: Geriatric Depression Scale (GDS) self report
Anxiety:Neuropsychiatric Inventory-Anxiety (NPI-A) subscale (collateral anxiety report)
Rating Anxiety in Dementia (RAID) (administered as a clinical interview to the patient
and the caregiver)
Geriatric Anxiety Inventory (GAI) self report
Worry: Penn State Worry Questionnaire-Abbreviated (PSWQ-A) self report
Quality of Life: Quality of Life in Alzheimer disease (QOL-AD)
Carer Outcomes
Depression: Patient Health Questionnaire (PHQ-9)
Distress: distress item from the NPI-A
Notes Peaceful Mind was provided by two master’s-level graduate-student clinicians and a
predoctoral intern supervised by clinical psychologists and a geriatric social worker. A
total of 12 weekly in-home sessions were provided and up to 8 brief telephone sessions,
for 6 months, with each session lasting 30 to 60 minutes
AD - Alzheimer’s disease
DLB - Dementia with Lewy bodies
VaD - Vascular Dementia
GAD - General Anxiety Disorder
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The author communicated that randomi-
sation was completed in blocks of four or
six stratified by CDR (Clinical Dementia
Rating scores), in SAS
Allocation concealment (selection bias) Unclear risk No details of method of concealment de-
scribed to allow judgment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information is provided
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All outcome measures were administered
in-person by independent evaluators who
were unaware of treatment assignment
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Stanley 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and reasons reported, intention-
to treat analyses
Selective reporting (reporting bias) Low risk All pre-specified outcomes reported
Other bias Low risk No other apparent bias
Tappen 2009
Methods RCT
Two-groups repeated measures design
Participants N = 36 (3M, 33F)
Dementia diagnosis according to NINCDS-ADRDA criteria
MMSE < 25 or less
Residents of long-term care facility
Mean age = 87.03
Age range 73-100
Range of length of stay in long-term care facility ranged from 160 to 1750 days
Ps that were mute were excluded
Interventions Individual therapeutic conversation based onmodified counselling provided individually
Usual care control group (usual care by staff provided in the long-term care facility),
described as a non-attention control group
Duration of intervention: 16 weeks
Outcomes Patient Outcomes
Depression: Montgomery-Asberg Depression Rating Scale (MADRS) (rated by clini-
cians)
Other behavioral outcomes:
Mood
Dementia Mood Assessment Scale (DMAS)
Alzheimer’s Disease and Related Disorders Mood Scale (AD-RD)
Outcomes measured at 16 weeks
Notes Therapeutic conversation of 30 minutes provided three times a week for 16 weeks
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details of randomisation described in
the study, insufficient information about
sequence generation
Allocation concealment (selection bias) Unclear risk No details of method of concealment de-
scribed to allow judgement
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Tappen 2009 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information provided
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Raters were blind to group assignment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition and reasons reported
Selective reporting (reporting bias) Low risk All pre-specified outcomes reported
Other bias Low risk No other apparent bias
Waldorff 2012
Methods RCT
Multicentre rater-blinded trial
1:1 randomisation
Treatment as usual beyond the level of usual care
Participants N = 330 (151M, 179F)
Clinical diagnosis of dementia using DSM-IV and NINCDS-ADRDA or McKeith
criteria
Patients with mild recently diagnosed dementia
Mean age = 76.2
Living in the community, age ≥ 50 years with MMSE ≥ 20
Recruited only patients receiving a conventional diagnostic evaluation by specialists
Excluded: Participants with severe somatic or psychiatric comorbidity, participating in
other interventions, living in nursing home at baseline, or having frontotemporal de-
mentia
Interventions Mutlifaceted and semi-tailored intervention consisting of counselling sessions, teaching,
education and outreach telephone support to patients and carers
Provided individually and as a group intervention
Duration of intervention 8 to 12 months
Control group was provided with overall information and guidance, and was directed
towards local support programmes (provided to both the control and treatment group)
Outcomes Patient Outcomes
Depression: Cornell Scale for Depression in Dementia (CSDD)
Other behavioral outcomes:
EuroQoL VAS (patient and proxy rated) (EQ-VAS)
Quality of Life in Alzheimer’s Disease (patient and proxy rated) (QoL-AD)
Neuropsychiatric Inventory Questionnaire (NPI-Q)
Alzheimer’s Disease Cooperative Study Activities of Daily Living Scale (ADSC-ADL)
Cognitive function: Mini Mental State Examination (MMSE)
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Waldorff 2012 (Continued)
Caregiver outcomes:
Geriatric Depression Scale (GDS)
EuroQoL VAS (Quality of Life) (EQ-VAS)
Outcomes measured at 6 months and at 12 months
Notes Intervention consisted of 6 or 7 counselling sessions, 5 educational courses, 5-8 telephone
calls within a 3- to 4-week intervals approximately
DSM-IV - Diagnostic and Statistical Manual of Mental Disorders, 4th edition
NINCDS-ADRDA - National Institute of Neurological and Communicative Diseases
and Stroke/Alzheimer’s Disease and Related Disorders Association
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was performed using a
computer programme
Allocation concealment (selection bias) Low risk Central allocation process was used to ran-
domise participants by a third party
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Raters were not employed by the same in-
stitution as study coordinators and coun-
sellors
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Raters were blind
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information on attrition and reasons pro-
vided, authors mention use of intention-
to-treat analyses
Selective reporting (reporting bias) Low risk All outcomes specified were reported
Other bias Low risk No other apparent bias
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abraham 1992 Participants did not fulfil criteria for a diagnosis of dementia
Cognitive impairment was measured and defined by scores < 80 on the Modified Mini-Mental State
Examination (3MS) (Teng 1987)
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Beck 2002 Intervention does not meet criteria for a psychological intervention
Intervention based on psychosocial activities (i.e. drawings, life review). Outcomes based on direct
observations of PwD
Brodaty 2003 Intervention does not meet criteria for a psychological intervention
Multi-component case management approach
Cheston 2003 This study was not conducted as a RCT
Feasibility study of a 10 week psychotherapy group aimed at reducing depression in people with
dementia
Dartigues 2008 Intervention does not meet criteria for a psychological intervention
RCT of cognitive training, and reminiscence therapy. Control group received psychoeducation for
carers
Finnema 2005 Intervention does not meet criteria for a psychological intervention
RCT evaluating an emotion oriented care program acknowledging residents’ experiences
Fischer-Terworth 2011 Intervention does not meet criteria for a psychological intervention
A TEACCH (Treatment and Education of Autistic and related Communication handicapped Chil-
dren)-based cognitive-behavioural and environmental intervention. This study was not conducted
as an RCT and the control group received occupational therapy
Fossey 2006 Intervention does not meet criteria for a psychological intervention
Cluster RCT of training and support to nursing home staff for managing agitation
Garland 2007 Intervention does not meet criteria for a psychological intervention
Intervention primarily targeted agitated behaviour. This study was not conducted as an RCT
Helcer 2012 Intervention does not meet criteria for a psychological intervention
RCT of memory training (MT), or CBT in conjunction with MT targeting hopelessness in PwD
Hinchliffe 1997 Intervention does not meet criteria for a psychological intervention
RCT of an intervention helping carers to cope with specific problem behaviours
Hyer 2008 Participants did not fulfil criteria for a diagnosis of dementia
Cognitive decline measured and defined by the MMSE (Folstein 1975). RCT of CBT in residents
with depression in long-term care
Joosten-Weyn Banningh2011 This study was not conducted as an RCT
Intervention was psychoeducation, cognitive rehabilitation in conjunction with CBT in people with
MCI
Kiosses 2010 Participants did not fulfil criteria for a diagnosis of dementia
Older adults with depression, cognitive decline, and disability. 23.3% had probable or definite
dementia. RCT comparing PATH (problem-solving therapy) to supportive therapy. No eligible
control or comparison group
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Kiosses 2011 Participants did not fulfil criteria for a diagnosis of dementia
Cognitive impairment measured and defined by scores 90 - 133 inclusive on the Dementia Rating
Scale (DRS). RCT comparing PATH (problem-solving therapy) to supportive therapy. No eligible
control or comparison group
Kolanowski 2011 Intervention does not meet criteria for a psychological intervention
RCT of an activities-based intervention in reducing agitation in nursing home residents with de-
mentia
Konnert 2009 Participants did not fulfil criteria for a diagnosis of dementia
Cognitive decline measured and defined by scores < 21 on the MMSE. RCT of a CBT intervention
in nursing home residents at risk of depression
Kurz 2012 Intervention does not meet criteria for a psychological intervention
RCT of cognitive rehabilitation with CBT elements
Laakkonen 2012 Intervention does not meet criteria for a psychological intervention
RCT of self-management for PwD based on a rehabilitation model
Lam 2010 Intervention does not meet criteria for a psychological intervention
RCT of skills training occupational therapy with CBT elements
Lichtenberg 2005 Intervention does not meet criteria for a psychological intervention
Intervention of behavioural activities delivered by nursing home assistants in dementia care units
Logsdon 2010 Intervention does not meet criteria for a psychological intervention
RCT of support groups for PwD that did not follow a psychological model (can not be described as
a supportive therapy intervention)
McSweeney 2012 Intervention does not meet criteria for a psychological intervention
Cluster RCT of a multidisciplinary specialist mental health consultation for depression in dementia
provided to care staff
Mittelman 1996 Intervention does not meet criteria for a psychological intervention
RCT of counselling and support for caregivers to delay nursing home placement in PwD
Onor 2007 Intervention does not meet criteria for a psychological intervention
RCT of a multimodal rehabilitation program of cognitive stimulation therapy and psychoeducation
for carers
Prick 2011 Intervention does not meet criteria for a psychological intervention
RCT of home-based physical exercise for people with dementia and their carers
Proctor 1999 Intervention does not meet criteria for a psychological intervention
RCT of a staff training and educational programme in residential care
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Rovner 2012 Intervention does not meet criteria for a psychological intervention
RCT of a Behavioural Activation (BA) program to prevent cognitive decline in MCI. No eligible
control or comparison group
Selbaek 2010 Intervention does not meet criteria for a psychological intervention
Staff nursing training program based on CBT. This study was not conducted as an RCT
Teri 2003 Intervention does not meet criteria for a psychological intervention
RCT of home-based exercise combined with caregiver training for delaying institutionalisation in
PwD
Vespa 2002 Intervention does not meet criteria for a psychological intervention
Evaluation of a creative activities-based therapy in reducing anti-social behaviour in PwD
Yesavage 1981 Participants did not fulfil criteria for a diagnosis of dementia. This study was not conducted as a
RCT. No eligible control or comparison group
Characteristics of studies awaiting assessment [ordered by study ID]
Carreel 1990
Methods Unknown whether this study was an RCT
Participants Elderly depressed older adults with dementia
Interventions Group sessions with therapeutic aim described as conversation groups
Outcomes Linguistic skills
Notes Article in French
Characteristics of ongoing studies [ordered by study ID]
Forstmeier 2011
Trial name or title Cognitive-Behavioral Treatment for Mild Alzheimer’s Patients and Their Caregivers (CBTA)
Methods RCT
Participants Inclusion criteria:
1) 50 to 95 years
2) meeting NINCDS-ADRDA criteria for probable or possible AD McKhann 1984
3) only AD cases with a mild dementia severity will be included, determined by the Clinical Dementia Rating
(CDR) scale, with scores 0.5 or 1, and by MMSE scores ≥20
4) Patient must suffer any non-cognitive symptom that motivates him/her to accept psychotherapeutic help
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Forstmeier 2011 (Continued)
5) A caregiver must be available to take part in most of the therapy sessions
Exclusion Criteria:
1) concomitant alcohol/drug addiction, history of malignant disease, severe organ failure, metabolic or hema-
tologic disorders, or other neurological conditions
Interventions CBT-based multi-component programme of 8 modules (diagnosis & goal setting; psycho-education; engage-
ment in pleasant activities; cognitive restructuring; live review; training caregiver in behavior management
techniques; interventions for the caregiver; and couples counselling)
20 weekly sessions (and 5 single sessions with caregiver).
The control group receives standard medical and psychosocial care (each patient/caregiver will receive at least
three out of six interventions: (1) psychoeducation on dementia and treatment of dementia (oral and written)
; (2) appropriate medical treatment; (3) social counseling by specialized staff; (4) memory training in group
setting; (5) self-help group for the patient; (6) self-help group for the caregiver)
Outcomes Primary patient outcomes
Geriatric Depression Scale (GDS)
Secondary patient outcomes
Neuropsychiatric Inventory (NPI), Bayer-Activities of Daily Living (B-ADL), Stress Coping Inventory (SCI)
, Apathy Evaluation Scale (AES)
Caregiver outcomes
Center for Epidemiologic Studies Depression Scale (CES-D), State Trait Anxiety Inventory (STAI), Anger-
in and anger-out scales of the State Trait Anger Expression Inventory (STAXI), Short-Form Health Survey
(SF-12), Zarit Burden Interview (ZBI), and Stress Coping Inventory (SCI)
Outcomes are measured at 15 weeks and 12 months
Starting date January 2011
Contact information Dr Simon Forstmeier, University of Zurich, s.forstmeier@psychologie.uzh.ch
Notes ClinicalTrials.gov Identifier: NCT01273272
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D A T A A N D A N A L Y S E S
Comparison 1. Psychological treatment versus treatment as usual
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Depression 6 439 Std. Mean Difference (IV, Fixed, 95% CI) -0.22 [-0.41, -0.03]
2 Anxiety RAID 2 65 Mean Difference (IV, Fixed, 95% CI) -4.57 [-7.81, -1.32]
3 Anxiety Self ratings 2 65 Std. Mean Difference (IV, Fixed, 95% CI) 0.05 [-0.44, 0.54]
4 Anxiety NPI-A 1 26 Mean Difference (IV, Fixed, 95% CI) -2.4 [-4.96, 0.16]
Comparison 2. Psychological intervention versus treatment as usual
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Quality of Life (Self ratings) 3 334 Mean Difference (IV, Fixed, 95% CI) 0.37 [-1.01, 1.75]
2 Quality of Life (Proxy ratings) 2 313 Mean Difference (IV, Fixed, 95% CI) 0.66 [-0.77, 2.09]
3 Activities of daily living 2 313 Std. Mean Difference (IV, Fixed, 95% CI) -0.13 [-0.35, 0.09]
4 Neuropsychiatric symptoms 2 311 Std. Mean Difference (IV, Fixed, 95% CI) 0.06 [-0.16, 0.28]
5 Cognition (Mini Mental State
Examination)
4 381 Mean Difference (IV, Fixed, 95% CI) -0.80 [-1.70, 0.11]
Comparison 3. Psychological intervention versus treatment as usual
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Carer Depression 3 337 Std. Mean Difference (IV, Fixed, 95% CI) 0.07 [-0.14, 0.29]
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Analysis 1.1. Comparison 1 Psychological treatment versus treatment as usual, Outcome 1 Depression.
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 1 Psychological treatment versus treatment as usual
Outcome: 1 Depression
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burgener 2008 19 3.3 (2.9) 14 4.3 (3.4) 7.4 % -0.31 [ -1.01, 0.38 ]
Burns 2005 20 5.4 (2.6) 20 5.5 (3.1) 9.3 % -0.03 [ -0.65, 0.59 ]
Spector 2012 21 10.38 (5.835) 18 16.72 (7.283) 8.0 % -0.95 [ -1.62, -0.28 ]
Stanley 2012 11 8.2 (2.86) 15 7.8 (5.95) 5.9 % 0.08 [ -0.70, 0.86 ]
Tappen 2009 15 15.13 (9.54) 15 19.13 (7.37) 6.8 % -0.46 [ -1.18, 0.27 ]
Waldorff 2012 130 5.05 (4.61) 141 5.77 (5.07) 62.7 % -0.15 [ -0.39, 0.09 ]
Total (95% CI) 216 223 100.0 % -0.22 [ -0.41, -0.03 ]
Heterogeneity: Chi2 = 6.33, df = 5 (P = 0.28); I2 =21%
Test for overall effect: Z = 2.30 (P = 0.022)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours treatment Favours usual care
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Analysis 1.2. Comparison 1 Psychological treatment versus treatment as usual, Outcome 2 Anxiety RAID.
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 1 Psychological treatment versus treatment as usual
Outcome: 2 Anxiety RAID
Study or subgroup
Favours
[experi-
mental] Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Spector 2012 21 13.57 (6.038) 18 17.89 (5.9) 74.8 % -4.32 [ -8.07, -0.57 ]
Stanley 2012 11 11.9 (6.92) 15 17.2 (9.89) 25.2 % -5.30 [ -11.76, 1.16 ]
Total (95% CI) 32 33 100.0 % -4.57 [ -7.81, -1.32 ]
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 2.76 (P = 0.0058)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours treatment Favours usual care
Analysis 1.3. Comparison 1 Psychological treatment versus treatment as usual, Outcome 3 Anxiety Self
ratings.
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 1 Psychological treatment versus treatment as usual
Outcome: 3 Anxiety Self ratings
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Spector 2012 21 7.25 (3.338) 18 6.78 (3.843) 60.4 % 0.13 [ -0.50, 0.76 ]
Stanley 2012 11 3.9 (3.57) 15 4.2 (5.2) 39.6 % -0.06 [ -0.84, 0.71 ]
Total (95% CI) 32 33 100.0 % 0.05 [ -0.44, 0.54 ]
Heterogeneity: Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours treatment Favours usual care
46Psychological treatments for depression and anxiety in dementia and mild cognitive impairment (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.4. Comparison 1 Psychological treatment versus treatment as usual, Outcome 4 Anxiety NPI-A.
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 1 Psychological treatment versus treatment as usual
Outcome: 4 Anxiety NPI-A
Study or subgroup
Favours
[experi-
mental] Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Stanley 2012 11 1.5 (2.84) 15 3.9 (3.83) 100.0 % -2.40 [ -4.96, 0.16 ]
Total (95% CI) 11 15 100.0 % -2.40 [ -4.96, 0.16 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.067)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours treatment Favours usual care
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Analysis 2.1. Comparison 2 Psychological intervention versus treatment as usual, Outcome 1 Quality of
Life (Self ratings).
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 2 Psychological intervention versus treatment as usual
Outcome: 1 Quality of Life (Self ratings)
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Spector 2012 21 34.05 (5.052) 18 32.61 (6.118) 15.0 % 1.44 [ -2.12, 5.00 ]
Stanley 2012 11 36.5 (4.28) 15 35.1 (6.64) 10.8 % 1.40 [ -2.81, 5.61 ]
Waldorff 2012 129 38.2 (6.6) 140 38.2 (6.8) 74.2 % 0.0 [ -1.60, 1.60 ]
Total (95% CI) 161 173 100.0 % 0.37 [ -1.01, 1.75 ]
Heterogeneity: Chi2 = 0.78, df = 2 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.52 (P = 0.60)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours usual care Favours treatment
Analysis 2.2. Comparison 2 Psychological intervention versus treatment as usual, Outcome 2 Quality of
Life (Proxy ratings).
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 2 Psychological intervention versus treatment as usual
Outcome: 2 Quality of Life (Proxy ratings)
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Spector 2012 21 34.25 (6.086) 18 31.72 (6.789) 12.3 % 2.53 [ -1.55, 6.61 ]
Waldorff 2012 130 32.6 (6.2) 144 32.2 (6.7) 87.7 % 0.40 [ -1.13, 1.93 ]
Total (95% CI) 151 162 100.0 % 0.66 [ -0.77, 2.09 ]
Heterogeneity: Chi2 = 0.92, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 0.91 (P = 0.36)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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Analysis 2.3. Comparison 2 Psychological intervention versus treatment as usual, Outcome 3 Activities of
daily living.
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 2 Psychological intervention versus treatment as usual
Outcome: 3 Activities of daily living
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burns 2005 20 7.5 (4.4) 20 9.9 (5.1) 12.4 % -0.49 [ -1.12, 0.14 ]
Waldorff 2012 130 55.3 (15.1) 143 56.6 (17.8) 87.6 % -0.08 [ -0.32, 0.16 ]
Total (95% CI) 150 163 100.0 % -0.13 [ -0.35, 0.09 ]
Heterogeneity: Chi2 = 1.46, df = 1 (P = 0.23); I2 =32%
Test for overall effect: Z = 1.15 (P = 0.25)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours treatment Favours usual care
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Analysis 2.4. Comparison 2 Psychological intervention versus treatment as usual, Outcome 4
Neuropsychiatric symptoms.
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 2 Psychological intervention versus treatment as usual
Outcome: 4 Neuropsychiatric symptoms
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Spector 2012 21 20.71 (18.031) 18 28.61 (13.69) 12.2 % -0.48 [ -1.12, 0.16 ]
Waldorff 2012 129 4.79 (3.82) 143 4.24 (4.36) 87.8 % 0.13 [ -0.10, 0.37 ]
Total (95% CI) 150 161 100.0 % 0.06 [ -0.16, 0.28 ]
Heterogeneity: Chi2 = 3.09, df = 1 (P = 0.08); I2 =68%
Test for overall effect: Z = 0.52 (P = 0.61)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours treatment Favours usual care
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Analysis 2.5. Comparison 2 Psychological intervention versus treatment as usual, Outcome 5 Cognition
(Mini Mental State Examination).
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 2 Psychological intervention versus treatment as usual
Outcome: 5 Cognition (Mini Mental State Examination)
Study or subgroup Control Experimental
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Burgener 2008 14 22.4 (7.6) 19 25.2 (3.1) 4.6 % -2.80 [ -7.02, 1.42 ]
Burns 2005 20 21.8 (3.9) 20 23.8 (4.1) 13.2 % -2.00 [ -4.48, 0.48 ]
Spector 2012 18 19.83 (5.973) 21 22.3 (4.497) 7.2 % -2.47 [ -5.83, 0.89 ]
Waldorff 2012 139 22.2 (4.8) 130 22.5 (3.9) 75.0 % -0.30 [ -1.34, 0.74 ]
Total (95% CI) 191 190 100.0 % -0.80 [ -1.70, 0.11 ]
Heterogeneity: Chi2 = 3.59, df = 3 (P = 0.31); I2 =17%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
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Analysis 3.1. Comparison 3 Psychological intervention versus treatment as usual, Outcome 1 Carer
Depression.
Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Comparison: 3 Psychological intervention versus treatment as usual
Outcome: 1 Carer Depression
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Spector 2012 21 3.2 (2.931) 18 2.94 (2.287) 11.6 % 0.10 [ -0.53, 0.73 ]
Stanley 2012 11 2.9 (2.7) 15 6.2 (4.74) 7.0 % -0.80 [ -1.61, 0.02 ]
Waldorff 2012 129 5.64 (5.45) 143 4.82 (5.7) 81.4 % 0.15 [ -0.09, 0.38 ]
Total (95% CI) 161 176 100.0 % 0.07 [ -0.14, 0.29 ]
Heterogeneity: Chi2 = 4.76, df = 2 (P = 0.09); I2 =58%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours treatment Favours usual care
A D D I T I O N A L T A B L E S
Table 1. Overview of characteristics of included studies
Study Sample Method Measures Intervention Outcome Data
Timepoints
Burgener 2008 n = 43
Inclusion criteria
(1) confirmed diag-
nosis of dementia
(AD, Lewybody, vas-
cular, frontal lobe, or
mixed dementia)
(2) CDR < 2.0
RCT Patient Outcomes
Depression
Geriatric Depression
Scale (GDS-15)
Other behavioral
outcomes
Rosenberg’s Self-Es-
teem Scale (SES)
Type
Multimodal CBT in-
cluding Tai
Chi, CBT, and sup-
port group
Duration
20 weeks
(note that interven-
tion lasted 40 weeks)
Outcome data in-
cluded in the Review
20 weeks
Baseline CDR and
MMSE
Treatment group
CDR 1.15
MMSE 24.8
Control group
Attention-control
educational program
Cognition
Mini-
Mental State Exami-
nation (MMSE)
Physical function
Intensity/Frequency
Tai Chi
3 times a week (60
minutes)
CBT
Out-
come data reported
(for both groups) at
20 weeks
control group en-
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Table 1. Overview of characteristics of included studies (Continued)
Control group
CDR 1.22
MMSE 22.9
Single leg stance
(SLS)
Berg Balance Scale
(BBS)
Cumulative Illness
Rating Scale (CIRS)
2 times a week (90
minutes)
Support group
2 times a week
(90 minutes, alter-
nating with CBT)
ters treatment at 20
weeks, scores at 40
weeks (representing
no treatment) not
available
Burns 2005 n = 40
Inclusion criteria
1) diagnosis of AD -
NINCDS-ADRDA
criteria
2) CDR of 1
3) MMSE ≥ 15
4) living in own
home with carer in
regular contact
5) ability to commu-
nicate verbally
RCT Patient Outcomes
Depression
Cornell Scale for De-
pression in Demen-
tia (CSDD)
Function
Activities of Daily
Living (BADLS)
Other patient out-
comes
Cognition
Mini-
Mental State Exami-
nation (MMSE)
Clinician’s
Interview-Based
Global Impression of
Change (CIBI)
Type
Psychody-
namic interpersonal
therapy based on in-
terpersonal theory
Duration
6 weeks
Outcome data in-
cluded in the Review
6 weeks
Medication
20% on antidepres-
sants
68%
on cholinesterase in-
hibitors
Baseline MMSE
Treatment group
MMSE 24.4
Control group
MMSE 21.5
Control group
Standard treatment
in AD, (general ad-
vice on diagnosis and
treatment of demen-
tia, with out-patient
review)
Carer outcomes
RevisedMemory and
Behavior Problems
Checklist (RMBPC)
- Carer’s reaction
Gen-
eral Health Ques-
tionnaire (GHQ-12)
Beck Depression In-
ventory (BDI-II)
(scores not reported)
Ways of Coping
Checklist (WCCL)
Intensity/Frequency
Once a week (50
minutes - of which
10 minutes are spent
with carer)
Outcome data re-
ported at 6 weeks
(end of the interven-
tion)
and 3 months
Spector 2012 n = 50
Inclusion criteria
1) Meet DSM-IV
criteria for mild to
moderate dementia,
CDR of 0.5, 1 or 2
2)Clinical anxiety,≥
11 on the RAID
3) Living in the com-
RCT Patient outcomes
Rating Anxiety in
Dementia (RAID)
Clinical Services Re-
ceipt Inventory
(CSRI)
Secondary outcomes
Hospital Anxiety
andDepression Scale
Type
CBT
identifying strategies
for feeling safe, calm-
ing thoughts and be-
havioural ex-
periments, with tele-
phone contact of-
fered between ses-
Outcome data in-
cluded in the Review
15 weeks
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Table 1. Overview of characteristics of included studies (Continued)
munity
4) Presence of carer
willing to participate
in the therapy
5) Ability to under-
stand and communi-
cate in English
6) Willing to engage
in therapy
Exclusion criteria
1) Co-morbid psy-
chiatric
disorder or challeng-
ing behaviour
2) Learning disabil-
ity or severe physical
illness
(HADS)
Quality of
Life-Alzheimer’sDis-
ease (QOL-AD) (self
and proxy ratings)
Neuropsychiatric In-
ventory (NPI)
Mini-
Mental State Exami-
nation (MMSE)
Cornell Scale for De-
pression in Demen-
tia (CSDD)
Quality of Caregiver
and Patient Relation-
ship (QCPR)
sions
Carers involved
Duration
15 weeks
Control group
Standard treat-
ment including med-
ication or no treat-
ment
Carer outcomes
Hospital Anxiety
andDepression Scale
(HADS)
Quality of Caregiver
and Patient Relation-
ship (QCPR)
Intensity/Frequency
10 sessions (60 min-
utes) for 15 weeks,
and telephone con-
tact
Outcome data re-
ported at 15 weeks
(end of intervention)
and 6 months
Stanley 2012 n = 32
Inclusion criteria
1) diagnosis of
dementia (confirmed
by the patient’s med-
ical provider)
2) an NPI-A ≥ 4
3) CDR score of 0.5
- 2.0
Exclusion criteria
-primary psychiatric
diagnosis of major
depression
-active psychosis,
bipolar disorder, ac-
tive suicidal intent
-recent verbal or
physical aggression
RCT Patient outcomes
Depression
Geriatric Depression
Scale (GDS) (self re-
port)
Quality of Life
Quality of
Life inAlzheimer dis-
ease (QOL-AD) (self
report)
Other outcomes
Anxiety
Neuropsychiatric In-
ventory-Anxi-
ety (NPI-A) subscale
(collateral report)
Rating of Anxiety
in Dementia (RAID)
(administered as a
clinical interview to
patient and carer)
Geriatric Anxiety In-
Type
CBT targeting anxi-
ety (self-monitoring/
deep breathing)
, writtenmaterials on
dementia education,
collateral stress and
communication
Carers involved as
coaches
Duration
6 months
Outcome data in-
cluded in the Review
6 months
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Table 1. Overview of characteristics of included studies (Continued)
ventory (GAI) (self
report)
Worry
Penn State Worry
Questionnaire-Ab-
breviated (PSWQ-A)
(self report)
Dementia diagnosis
AD (62.5%), DLB
(3.1%), VaD (9.4%)
and 25% dementia
not otherwise speci-
fied (NOS)
Principal DSM-IV
Diagnoses
43.8% GDA, 18.8%
other anxiety disor-
der, 43.8% comor-
bid anxiety and de-
pression, 34.4% no
diagnosis, 3.1% a de-
pression diagnosis
Dementia Severity
46.9% CDR of 0.5
or 1
Medication
75% on at least one
psychotropic medi-
cation
Control group
Receives diagnostic
feedback
Carer Outcomes
Depression
PatientHealthQues-
tionnaire (PHQ-9)
Distress
Distress item from
the NPI-A
Intensity/Frequency
12 weekly sessions
(30 to 60 minutes)
for 3 months, 8 tele-
phone booster ap-
pointments during
months 3-6
Outcome data re-
ported at 3 and 6
months (endof inter-
vention)
Tappen 2009 n = 36
Inclusion criteria
1) diagnosis of prob-
able AD, NINCDS-
ADRDA criteria
2) MMSE ≤ 25
3) ability to speak
English
Exclusion criteria
1) Individuals en-
tirely mute
RCT Patient Outcomes
Depression
The Mont-
gomery-Asberg De-
pression Rating Scale
(MADRS)
Type
Modified coun-
selling offered indi-
vidually consisting of
therapeutic conver-
sation
Duration
16 weeks
Outcome data in-
cluded in the Review
16 weeks
Mean stay in nursing
care
Treatment group
561 days
Control group
Usual care (not an at-
tention-control
group)
Other Patient Out-
comes
Mood
Dementia Mood As-
Intensity/Frequency
3 times a week (30
minutes)
Outcome data re-
ported at 16
weeks (end of inter-
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Table 1. Overview of characteristics of included studies (Continued)
Control group
595 days
Baseline MMSE
Treatment group
10.60
Control group
12.26
sessment Scale
(DMAS)
The Alzheimer’s Dis-
ease and Re-
lated Disorders (AD-
RD) Mood Scale
vention)
Waldroff 2012 n = 330
Inclusion criteria
1) community-
dwelling
2) age 50 years
3) MMSE 20
4) diagnosis of prob-
able AD, mixed AD
with vascular com-
ponents or DLB, es-
tablished in the last
12 months, meeting
DSM-IV, NINCDS-
ADRDA or the
McKeith 1996 crite-
ria for DLB
Exclusion criteria
1) severe somatic or
psychiatric
comorbidity
2) participating
in other intervention
studies
3) residing in a nurs-
ing home at baseline
5) diagnosis of fron-
totemporal demen-
tia
RCT Patient Outcomes
Depression
Cornell Scale for De-
pression in Demen-
tia (CSDD)
Function
Alzheimer’s Disease
Cooper-
ative Study Activities
of Daily Living Scale
(ADSC-ADL)
Quality of Life
Quality of Life in
Alzheimer’s Disease
(patient and proxy
ratings) (QoL-AD)
Other outcomes
EuroQoL VAS (pa-
tient and proxy rat-
ings Quality of Life)
(EQ-VAS)
Neuropsychiatric In-
ventory
Questionnaire (NPI-
Q)
Mini
Mental State Exami-
nation (MMSE)
Type
Mutlifaceted
and semi-tailored in-
tervention consisting
of counselling ses-
sions, teaching, edu-
cation and outreach
telephone support to
patients and carers.
Provided
individually and as a
group intervention
Duration
8 to 12 months
Outcome data in-
cluded in the Review
12 months
Dementia diagnosis
AD72.4%,Mixed or
VaD 24.8%, DLB 2.
7%
Medication
93.
3% on cholinesterase
inhibitors
1% memantine
Baseline MMSE
Treatment group
Control group
Provided with over-
all information and
guidance, di-
rected towards local
support programmes
(provided to both
the control and treat-
ment group)
Carer outcomes
Depression
Geriatric Depression
Scale (GDS)
Other outcomes
Quality of Life
EuroQoL VAS (EQ-
VAS)
Intensity/Frequency
6 counselling ses-
sions (plus one op-
tional session)
5 educational courses
(2 hours)
5-8 telephone sup-
port calls within 3-4
week intervals
Outcome data re-
ported at 6 and 12
months (endof inter-
vention)
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24.0
Control group
24.1
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
MEDLINE (Ovid SP) search strategy
1. exp Dementia/
2. Delirium/
3. Wernicke Encephalopathy/
4. Delirium, Dementia, Amnestic, Cognitive Disorders/
5. dement*.
6. alzheimer*.mp.
7. (lewy* adj2 bod*).mp.
8. deliri*.mp.
9. (chronic adj2 cerebrovascular).mp.
10. (“organic brain disease” or “organic brain syndrome”).mp
11. (“normal pressure hydrocephalus” and “shunt*”).mp.
12. “benign senescent forgetfulness”.mp.
13. (cerebr* adj2 deteriorat*).mp.
14. (cerebral* adj2 insufficient*).mp.
15. (pick* adj2 disease).mp.
16. (or jcd or cjd).mp.
17. huntington*.mp.
18. binswanger*.mp.
19. korsako*.mp.
20. or/1-19
21. “cognit* impair*”.mp.
22. exp *Cognition Disorders/
23. MCI.ti,ab.
24. ACMI.ti,ab.
25. ARCD.ti,ab.
26. SMC.ti,ab.
27. CIND.ti,ab.
28. BSF.ti,ab.
29. AAMI.ti,ab.
30. MD.ti,ab.
31. LCD.ti,ab.
32. QD.ti,ab.
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33. AACD.ti,ab.
34. MNCD.ti,ab.
35. MCD.ti,ab.
36. (“N-MCI” or “A-MCI” or “M-MCI”).ti,ab.
37. ((cognit* or memory or cerebr* or mental*) adj3 (declin* or impair* or los* or deteriorat* or degenerat* or complain* or disturb*
or disorder*)).ti,ab
38. “preclinical AD”.mp.
39. “pre-clinical AD”.mp.
40. (“preclinical alzheimer*” or “pre-clinical alzheimer*”).mp
41. (aMCI or MCIa).ti,ab.
42. (“CDR 0.5” or “clinical dementia rating scale 0.5”).ti,ab
43. (“GDS 3” or “stage 3 GDS”).ti,ab.
44. (“global deterioration scale” and “stage 3”).mp.
45. “Benign senescent forgetfulness”.ti,ab.
46. “mild neurocognit* disorder*”.ti,ab.
47. (prodrom* adj2 dement*).ti,ab.
48. or/21-47
49. 20 or 48
50. depress*.ti,ab.
51. dysthymi*.ti,ab.
52. “adjustment disorder*”.mp.
53. “mood disorder*”.mp.
54. “affective disorder*”.mp.
55. “affective symptom*”.mp.
56. anxiety.mp.
57. anxious.mp.
58. ?phobi*.mp.
59. “panic disorder”.mp.
60. BPSD.ti,ab.
61. “behavioural and psychological symptoms of dementia”.mp.
62. (“neuropsychiatric symptom*” or NPS).mp.
63. exp Behavioral Symptoms/ or Psychomotor Agitation/
64. Depression/
65. Anxiety/ or Anxiety Disorders/
66. or/50-65
67. 49 and 66
68. (psychotherapy or “cognitive therap*”).mp.
69. “behaviour*”.mp.
70. counselling.ti,ab.
71. “cognitive analytic therapy”.mp.
72. “interpersonal therap*”.mp.
73. relaxation.mp.
74. (“non-pharmacological intervention*” or “non-pharmacological treatment*”).mp
75. “psychodynamic therap*”.mp.
76. (behavi* adj2 therap*).ti,ab.
77. “rational insight therap*”.mp.
78. “problem-solving therap*”.mp.
79. CBT.ti,ab.
80. psychosocial.ti,ab.
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81. psycho-social.ti,ab.
82. exp Psychotherapy/ or Psychotherapy, Multiple/ or Psychotherapy, Group/ or Psychotherapy, Brief/ or Psychotherapy, Rational-
Emotive/
83. or/68-82
84. 67 and 83
85. randomized controlled trial.pt.
86. controlled clinical trial.pt.
87. random*.ab.
88. trial.ab.
89. groups.ab.
90. or/85-89
91. (animals not (humans and animals)).sh.
92. 90 not 91
93. 84 and 92
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A new author has been included in this review. Cognition has been included as an additional secondary outcome.
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